Page 1

Vo l u m e x x v i i, N o . 8 N o v e m b e r 2 013

Screening for risky substance use Clinics implement a new model in primary care By Pam Pietruszewski, MA

D

uring the past five years, more than 80 Minnesota primary care clinics have implemented the DIAMOND program (Depression Improvement Across Minnesota, Offering a New Direction) to treat patients with depression. In 2011, the Institute for Clinical Systems Improvement (ICSI), in partnership with the Pittsburgh Regional Health Initiative and the Wisconsin Collaborative for Healthcare Quality, received a $3.5 million grant from the Agency for Healthcare Research and Quality. The goals of the grant were to combine the evidence-based “Screening, Brief Intervention and Referral to Treatment” (SBIRT) program with the DIAMOND program to screen patients for risky alcohol or drug use, as well. As part of the grant, all three partners helped primary care clinics in their states to train clinic staff, build patient and community awareness of the underserved conditions, develop patient registries to track patients progress, and support sustainability for the model.

One team, one bill

During the past two years, ICSI has helped 34 primary care clinics in Minnesota imScreening for risky substance use to page 12

Comprehensive care for knee surgery By Owen R. O’Neill, MD

P

hysician-owned practices are adapting to the challenges of health care reform that stress the provision of high-quality care at lower cost with improved patient satisfaction. Twin Cities Orthopedics, a large physician-owned practice that has been in business for over 60 years, set out to further explore ways to innovate and lead in the evolving health care delivery system that would do just that. The resulting TCO Excel Surgery & Recovery Program, which offers a bundled price for knee replacement surgery, has One team, one bill to page 10


Clinicians Love Amazing Charts Here are some reasons why...

“ This EHR is so easy to use, one of my nurses just said she wants to ‘marry’ Amazing Charts!” – Peter Sundwall Jr., MD, Family Medicine “ A Blue Cross Blue Shield auditor said our paperless practice organized around Amazing Charts was the best she has seen.” – Nisha Chellam, MD, Internal Medicine “ Our practice loves Amazing Charts because it’s easy to use in the exam room. Compared to other EHRs we tried, we can document more with fewer clicks.” – Scholastica Nwodo, NP, Family Medicine

Start your FREE trial today! amazingcharts.com/trial 866-382-5932


CO N TE N T S

November 2013 • Volume XXVII, No. 8

MINNESOTA HEALTH CARE ROUNDTABLE

Features One team, one bill

1

Comprehensive care for knee surgery By Owen R. O’Neill, MD

Screening for risky substance use

1

Clinics inplement a new model in primary care By Pam Pietruszewski, MA

Departments Capsules

4

Medicus

7 Interview 8 Jeffrey Tucker, EFPM

Integrity Health Network, LLC

Ophthalmology Keratoconus

18

By Sumitra S. Khandelwal, MD, and Sherman W. Reeves, MD, MPH

Physical medicine/ 30 Rehabilitation Cognition and cancer

Models of care

Turning health programming inside out

16

By Nancy Hutchison, MD, and Mary V. Radomski, PhD, OTR/L

Letters

By Emily Karlen, MPT

38

By Thomas C. Votel, MD

Post-acute care Fixing cracks in the system

Special focus: Rural health Crossing the shaky bridge 20 By Terry J. Hill, MPA, and Eric Shell, CPA, MBA Southern Prairie Community Care By Keith Halleland, JD, and Mary Fischer, MSW

22

FOrty-First Session

Community health needs assessment By Colleen Spike, RN, and Mary Hildebrandt, PHN

24

Teleradiology By Nihar Shah, MD

26

The Independent Medical Business Newspaper

www.mppub.com

Publisher Mike Starnes mstarnes@mppub.com Senior Editor Donna Ahrens dahrens@mppub.com ASsociate Editor Janet Cass jcass@mppub.com

Thursday, April 17, 2014 1:00–4:00 PM, Symphony Ballroom Downtown Minneapolis Hilton and Towers

Objectives: We will discuss the evolution of post-acute care and illustrate the dynamic potential it holds. From the hospital to the physician to skilled nursing, rehab, and home care, we will present perspectives from across the care continuum. We will investigate communication problems between care team members and present potential solutions. We will examine how elements of health care reform like ACOs and insurance exchanges can drive both improvement in and higher utilization of post-acute care. We will discuss the tools that are necessary for post-acute care to reach its full potential.

Please send me ____ tickets at $95.00 per ticket. Mail orders to Minnesota Physician Publishing, 2812 East 26th Street, Minneapolis, MN 55406. Tickets may also be ordered by phone 612.728.8600 or fax 612.728.8601. Name Company Address

Art Director Alice Savitski asavitski@mppub.com

City, State, ZIP

Office Administrator Amanda Marlow amarlow@mppub.com

Telephone/FAX

Account Executive Iain Kane ikane@mppub.com

Background and focus: Postacute care is becoming an increasingly important component of health care delivery. It is also becoming increasingly community-based. Medical advances are dramatically expanding the range of access to these services and, at the same time, creating a larger number of problems providing them. Choppy access to electronic medical records and ensuing medication management complications, as well as problems with care team coordination, can impede the goal of improving outcomes while lowering costs.

Card #  Check enclosed

Exp. Date  Bill me

 Credit car (Visa, Mastercard, American Express or Discover)

Signature Minnesota Physician is published once a month by Minnesota Physician Publishing, Inc. Our address is 2812 East 26th Street, Minneapolis, MN 55406; phone 612.728.8600; fax 612.728.8601; email mpp@mppub.com. We welcome the submission of manuscripts and letters for possible publication. All views are opinions expressed by authors of published articles are solely those of the authors and do not neccessarily represent or express the views of Minnesota Physician Publishing, Inc. or this publications. The contents herein are believed accurate but are not intended to replace medical, legal, tax, business or other professional advice and counsel. No part of the publication may be reprinted or reproduced within written permission of the publisher. Annual subscriptions (12 copies) are $48.00/ Individual copies are $5.00.

Email

Please mail, call in, or fax your registration by 4/7/2014 November 2013 Minnesota Physician

3


Capsules

Allina, Children’s Mother Baby Center Expands Allina Health and Children’s Hospitals and Clinics of Minnesota has announced an expansion of the Mother Baby Center with a 50,000-square-foot addition at Coon Rapids-based Mercy Hospital. The twostory addition will incorporate a single-story clinic that is part of the current complex.

Baby Clinical Service Line of Children’s Hospitals and Clinics of Minnesota.

Minnesota Hospital Association Gets Safety Funding

According to Allina officials, plans for the addition include two operating rooms, 13 labor/ delivery/recovery rooms, eight special care nursery rooms, 19 postpartum rooms, and a skyway that will connect to Mercy Hospital operating rooms.

The U.S. Centers for Medicare & Medicaid Services (CMS) has awarded the Minnesota Hospital Association (MHA) Hospital Engagement Network (HEN) $4.5 million. It is one of six hospital engagement networks to be selected to develop and share new strategies and outcomes with hospitals across the nation after competing in the federal Partnership for Patients program.

The Coon Rapids City Council approved the site plan at a meeting on Oct. 1. Construction is scheduled to begin in December and will be completed in late March or early April 2015, according to Jennifer Olson, executive director and vice president of operations at Mother

The U.S. Department of Health and Human Services created the Partnership for Patients program in 2011 to improve health care quality, safety, and affordability with specific goals to decrease preventable hospital-acquired conditions by 40 percent and hospital 30-day

readmissions by 20 percent. MHA HEN and the other networks will use this funding to develop advances for severe sepsis and septic shock, clostridium difficile (C. diff), and iatrogeneic delirium. They will also focus on increasing the safety of workers and hospital culture and reducing the number of hospital-acquired conditions and readmissions.

U of M, Harvard Unite Against Diabetic Kidney Disease The National Institutes of Health has awarded the University of Minnesota and Harvard University $24.3 million to study a potential treatment for kidney disease in patients who have type 1 diabetes. The universities will partner on the five-year clinical trial, which is a part of the Preventing Early Renal Function Loss in Diabetes (PERL) consortium. Researchers will evaluate

the possible benefits of allopurinol, an FDA-approved drug that can lower uric acid, in reducing kidney function loss. Past studies from the Joslin Diabetes Center and other sources have linked high levels of uric acid to an increased risk of kidney complications in people with diabetes. The trial will be led by Michael Mauer, MD, professor of pediatrics and medicine at the University of Minnesota Medical School, and Alessandro Doria, MD, PhD, MPH, associate professor of medicine at Harvard Medical School and associate professor in the Department of Epidemiology at the Harvard School of Public Health. Luiza Caramori, MD, MSc, PhD, assistant professor of medicine and pediatrics at the University of Minnesota Medical School, will direct the study. “Data indicates that moderately high serum uric acid levels predispose to diabetic kidney disease. However, we don’t know whether this is due to uric acid itself or to something else

Orthopaedic

Radio Drive

Bl

n

7 DAYS A WEEK

o ds Hu

Urgent Care

High Pointe

vd

Providing walk-in care for: • Fractures • Joint Pain • Dislocations • Sports Injuries • Sprains and Strains • Concussions • Muscle Pain

High Pointe Health Campus Off I94 and Radio Drive 651.439.8807 or 800.423.1088 www.stcroixortho.com

Monday - Friday 1:00 p.m. to 8:00 p.m. Saturday & Sunday 8:00 a.m. to noon • No appointment is necessary • All patients are seen by a physician

4

Minnesota Physician November 2013

URGENT CARE


that goes together with it. That’s why this study is important—to determine if uric acid is the culprit or not,” says Doria. An estimated 500 patients with type 1 diabetes and a higher risk of losing kidney function will take part in the trial. For three years, half will take allopurinol, while the other half take a placebo. Research will be done at institutes in the PERL consortium, including the University of Minnesota. Participant recruitment could begin as early as this October, officials say. “If we see a benefit of allopurinol on slowing progression of diabetic kidney disease, this will become a standard addition to the treatment of diabetic kidney complications, especially given that allopurinol is relatively inexpensive and safe,” says Caramori.

Researchers studied 756 women with node-positive breast cancer who had undergone chemotherapy treatment. Of these, 637 had both axillary and sentinel lymph node surgeries. The new, less invasive option accurately determined the presence of cancer in 91 percent of women in the study, including 255 with node-negative breast cancer and 382 with continuing node-positive disease. The study had a false negative rate of 12.6 percent, which was substantially lower when dual tracers, blue dye, and radiolabeled colloid were used to identify sentinel lymph nodes. When two or more sentinel lymph nodes were removed, the rate dropped below 10 percent. Full results of the study were published online in the Oct. 9 issue of JAMA.

Physician Driven. Patient Inspired.

“The“The timetime they they save save me meeting reporting me meeting requirements allowsallows me tome spend reporting requirements to spend more patients.” more time with patients.” — Christopher Wenner, Wenner,MD, MD,Clinic ClinicOwner Owner – Christopher Integrity Network member, Cold Spring Integrity Health Health Network member, Cold Spring

Helping Independent Hospitals and Clinics compete: Helping Independent Hospitals • Referral network of 215 primaryand and Clinics specialtycompete: • Nphysicians etwork of over 200 physicians and providers • QI/P4P Measurement development & reporting

Results of Sentinel Node Surgery Study Reported in JAMA A procedure called sentinel lymph node surgery can identify if cancer remains in the lymph nodes of patients with node-positive breast cancer after chemotherapy, according to results of a study conducted through the American College of Surgeons Oncology Group. The majority of breast cancer patients whose disease has spread to their lymph nodes have surgery to remove most of the lymph nodes in their armpit area after chemotherapy to determine if cancer is still present. Sentinel lymph node surgery is less invasive, removing only a few lymph nodes that are the most likely to contain cancer. This lessens the chances of surgical complications like numbness and arm swelling, according to Judy Boughey, MD, a breast surgeon at Mayo Clinic. “Since treatment with chemotherapy before surgery can eliminate cancer in the lymph nodes in some patients, we were interested in evaluating whether sentinel lymph node surgery could successfully identify whether cancer remained in the lymph nodes after chemotherapy,” says Boughey.

Mankato Nurses, Mayo Reach Agreement After five months of negotiations, 470 nurses represented by the Minnesota Nurses Association (MNA) at Mayo Health Systems Clinic agreed to a new three-year contract at the Mankato hospital, averting a possible strike. Changes in contract terms address quality of care for patients and give nurses more input on staffing levels, schedules, and workload without fear of retaliation, MNA officials say. An MNA statement said the nurses were working to gain the power to make bedside decisions about patient care, stop patient intake when patient volumes were getting to a point they weren’t comfortable with, and review the hospital’s staffing models under the acuity-based care system it is moving to. They also wanted training for the charge nurses whose job it is to assess patients in the acuity system. The issues gained community attention at meetings, public events, and an informational picket outside the hospital on Sept. 17. “We’ve got the words that will guide hospital practices toward safe staffing, but we still need a commitment from Mayo Capsules to page 6

• Q1/P4P Measurement development & reporting

• Competitive group purchasing contracts to control

costs group purchasing contracts to control • Cyour ompetitive •your Latest in EHR & Web Portal technology costs • Partnering with health plans on new models of care

• Assistance in finding an EHR to meet your needs

• Partnering with hospitals, clinics and employers to work on clinical integration • Partnering with health plansand on delivery new models of care • Data Warehouse under development. Information is

• Partnering with hospitals, clinics and employers to key to competing and improving quality work on clinical integration and delivery • Marketing, risk management, clinic staff training strategies to development. leverage exciting new • •DDeveloping ata Warehouse under Information Accountable Care Organizations, isopportunities: key to competing and improving quality Medical Home, Baskets of Care

• Marketing, management, clinic staff training Our risk independent physicians keep hometown healthcare where it belongs.

• Developing strategies to leverage exciting new opportunities: Accountable Care Organizations, Medical Home, Baskets of Care Jeff Tucker, CEO (jtucker@ihnhealth.com)

Our Independent physicians keep Nyenhuis, COO it belongs. hometownRachael healthcare where (rnyenhuis@ihnhealth.com)

888.722.8802

Jeffrey L. Tucker, CEO jtucker@ihnhealth.com Delivering a network of solutions 218.722.8802.112

IntegrityHealthNetwork.com Melissa Larson, COO mlarson@ihnhealth.com 218.722.8802.115

888.722.8802 Delivering a network of solutions IntegrityHealthNetwork.com

November 2013 Minnesota Physician

5


Capsules from page 5

Mankato before we can all rest easy that all patients are being properly cared for,” said Chad Weiler, RN, co-chair of the bargaining unit and member of the MNA negotiations committee. “We look forward to the positive, professional, and solutionbased input from our nurses and all our staff members, as we work in the best interest of our patients, their families, the communities we serve and the sustainability of our organization,” said Ryannon Frederick, RN, chief nursing officer for Mayo Clinic Health System in southwest Minnesota.

New Cleaning Method Comes to Fairview Fairview Southdale Hospital will soon become one of the first hospitals in Minnesota to use cleaning robots that emit ultraviolet (UV) light rays to disinfect patients’ rooms and bathrooms, operating rooms,

and staff locker rooms. On Oct. 9, the Edina hospital joined more than 100 hospitals in the U.S. that are already using the new cleaning technology. The robots, which cost $80,000 each, use pulsed xenon UV light that is 25,000 times more powerful than the sun to eliminate harmful bacteria, bacteria spores, viruses, and fungi on all surfaces in a room and in the air. “We will still do our complete, hands-on cleaning routine,” says Courtney Nelson, director of environmental services at Fairview Southdale. “But this additional step will allow us to reach places that are very challenging to disinfect manually, such as the ceiling.” Here’s how it works: After standard cleaning procedures are complete, a portable robot is brought into the room, positioned on one side of the bed, and set to begin the automated cleaning sequence. Once complete, the process is repeated on the other side of the bed and in the bathroom. The total cleaning time for one room is 15 minutes. Because the robots

use UV light rays, there is no chemical residue. According to officials, the technology is effective against even the most threatening pathogens, including Clostridium difficile (C. diff), norovirus, influenza, and staph bacteria, including methicillin-resistant staphylococcus aureus (MRSA). Use of the robot necessitates caution, however, as people cannot be in the room while the machine is operating. Hospitals place warning signs on the doors of rooms while they are being cleaned, and a motion sensor on the robot will automatically disable the machine if anyone enters the room.

Regions Hospital Reduces Unneeded Blood Transfusions

per month. The hospital’s pathology department developed and implemented the decision-support tool for its electronic medical record in partnership with the American Red Cross to improve appropriate use of red blood cells based on the latest evidence-based clinical guidelines. The program reduced the hemoglobin trigger, the point at which doctors begin a transfusion, to levels below 7 g/dl. When transfusions are needed, they are initiated at cautious levels of about one unit at a time. According to a 2012 analysis of blood use at 464 hospitals, more than 802,000 units of blood and $165 million in costs could be saved annually if every hospital in the U.S. adopted these evidence-based best practices.

Regions Hospital recently announced that a technology they have used since 2011 has reduced blood transfusions by about 14 percent, or 94 units

Are you satisfied with your claims processing? You will be with ClaimLynx! Every medical practice depends on cash flow. Very few people understand the required processes between when a doctor sees a patient and how/when insurance reimbursement is disbursed. We make these steps simple for you. Among the services we offer: • Direct, real time verification of eligibility • Secure online access to claims tracking • Secure online access to claims correction • Never miss a payment due to late filing • We handle every kind of insurance and every medical specialty • Less time on paperwork, more time with patients

6

ClaimLynx is used by many national clearinghouses. You may already be using our services and not know it. Shorten your submission route and remittance time—go straight to the payer using ClaimLynx. Every practice is unique and whether a solo practitioner or large multi-specialty group (and everything in between) we can tailor a solution to your claims processing needs that will maximize your benefits.

Claims processing is an art. Let us show you the difference we can make

For more information please contact: Russel Campbell info@claimlynx.com 10700 Old County Road 15 Suite 200, Plymouth, MN 55441

www.claimlynx.com

952-593-5969

Minnesota Physician November 2013


Medicus Yun Shin Chun, MD, FACS, has joined Allina Health’s Virginia Piper Cancer Institute, Minneapolis, as a staff surgeon and medical director of hepato-pancreatobiliary programs. Previously a staff surgeon and assistant professor at Fox Chase Cancer Center, Philadelphia, she graduated from New York Medical College, received general surgery Yun Shin training at Mayo Clinic, and completed a Chun, MD surgical oncology fellowship at M.D. Anderson Cancer Center, Houston. Sanjay Chaudhary, MD, has joined the Critical Care department at Essentia Health– St. Mary’s Medical Center, Duluth. Boardcertified in internal medicine and nephrology, he earned a medical degree from B.P. Koirala Institute of Health Sciences in Dharan, Nepal, and served a residency in internal medicine at Creighton University Medical Center, Omaha. Sanjay He completed fellowships in Chaudhary, MD nephrology and critical care medicine at Mayo Clinic. Swati Prasad, MD, a hospitalist, has also joined Essentia Health–St. Mary’s Medical Center, Duluth. She graduated from Nepal Medical College, Kathmandu, and served an internal medicine residency at Creighton University Medical Center, Omaha. Swati Prasad, MD

David Rothenberger, MD, assumed the role of head of the University of Minnesota Department of Surgery in October. He graduated from Tufts University School of Medicine, Boston; completed a general surgery residency at St. Paul–Ramsey Hospital; and completed a fellowship in colon and rectal surgery at the University of Minnesota. Previously, he held the John P. Delaney Chair of Clinical Surgical Oncology at the University of Minnesota, where he had been the deputy chairman of the department of surgery since 2006. Joseph Westermeyer, MD, PhD, has received the R. Brinkley Smithers Distinguished Scientist Award from the American Society of Addiction Medicine. Chief of psychiatry services at Minneapolis Veterans Administration Health Care System and a professor of psychiatry at the University of Minnesota, Westermeyer completed medical school and psychiatry residency at the University of Minnesota. Imran Khawaja, MD, has been named medical director of the Minnesota Regional Sleep Disorders Center at Hennepin County Medical Center (HCMC). He earned a medical degree from King Edward Medical University, Lahore, Pakistan; completed Imran a psychiatry residency at Khawaja, MD New York Medical College, Valhalla, N.Y.; and completed a sleep medicine fellowship at Mayo Clinic. Previously, Khawaja practiced psychiatry and sleep medicine at the Minneapolis Veteran’s Administration Medical Center. Christine Tompkins, MD, has joined HCMC’s pediatrics department. She graduated James Wetmore, MD from the University of Nebraska Medical Center, Omaha; completed a pediatrics residency at the University of Connecticut, Farmington; and completed a pediatrics fellowship at Brown University, Providence, R.I. James Wetmore, MD, has joined HCMC’s nephrology department. He graduated from University of Texas Southwestern Medical School, Dallas; completed an internal medicine residency at University of Alabama, Birmingham; and served a nephrology fellowship at University of California, San Francisco. November 2013 Minnesota Physician

7


Interview

Upholding the independent practice P  lease tell us about the background and mission of Integrity Health Network.

Jeffrey Tucker, EFPM Integrity Health Network, LLC Jeffrey Tucker has worked in health care administration for nearly 25 years. He has been CEO and president of Integrity Health Network since 2010. His experience has included health plan negotiations and contract administration, management, budgeting and financial management, investment management, quality improvement and pay-for-performance programs, care coordination oversight, marketing, and outreach. In his work in developing clinic and hospital networks, Tucker has also focused on electronic health records, e-clinics, e-commerce, electronic prescribing, and finding ways technology can facilitate greater communication: between physicians, between physicians and hospitals, and between providers and patients.

8

We are a merger (2010) of two long-standing names in the health care marketplace: Northstar Physicians Network (formed in 1985) and Northland Medical Associates (formed in 1979). Our mission is to provide an innovative model of care inspired by and centered on our patients. We believe in providing a balanced marketplace through competition.

W  hat are some of the biggest challenges you face? We face state and federal health reform that favors—in fact, seems to force—consolidation in the marketplace, creating fewer and fewer huge corporate health care systems and reducing competition in the marketplace. The ramifications of this include the possibility of losses of innovation, increased costs due to decreased competition, and a loss of choices for care.

W  hat does “independent practice” mean? Independent practice, by our definition, is any provider or facility that has the desire to remain independent of the large corporate health care systems and exercise a degree of control over their own future. It means that decisions are made in the exam room, not the boardroom. Simply stated, independent practice means that one or more physicians have decided to practice the way medicine has traditionally been practiced—that is, unconstrained by the demands of a larger organization, which would otherwise employ the physician and/or providers. Though each practice may work in collaboration with other medical entities, decision-making, especially as it pertains to patient treatment and referrals to other physicians, is not dictated by a large corporate organization. The result is that independent practitioners often have much greater latitude in terms of treatment and referral options than do employed physicians. This can be particularly important in cases where a corporate administrator insists on referrals to a financially productive but professionally substandard physician within a closed system. It means the freedom to always focus on what is best for patients.

Minnesota Physician November 2013

W  hat are the best improvements the Integrity Health Network model can bring to health care delivery? We bring collaboration and an unrelenting pursuit of quality. This means not bought-and-paidfor quality like some systems are content doing through expensive magazine ads, but actual patient-centered quality focused on better care and higher patient satisfaction.

W  hat are some of the differences between health care delivery in the outstate areas vs. the metro area? In the metro area you generally have various specialties within a much smaller radius than in outstate or rural areas, where we rely on telemedicine and shared recruitment of specialties to try to fill community health needs.

W  hat is your opinion of state government’s role in rural health care policy? Policy and legislation, beginning in 2007–2008, have heavily favored large systems; small organizations and independent practices have been faced with many challenges in response to this. Any government role in health care delivery should be kept at a supportive and advisory level. There is no question that health care has its share of challenges, but legislating improvement has not been the best answer. Instead of getting help in understanding the problems and then support in resolving them from within, health care has been handed a book of rules and restrictions that are in some cases unclear, and has been told, “Figure this out and make it work,” with the not-so-subtle undertone of “or else we’ll do it for you.” Sadly, this has extended even higher, to the federal level, as well.

H  ow will MNsure (the state’s online health exchange) affect health care delivery in greater Minnesota? Anecdotally, we are hearing about employee hours being cut and the need for patients to take on more jobs to make ends meet. We are also seeing large payers focus on narrow networks and signing with only one or two large health systems and leaving other providers out. We are looking at the very real possibility of loss of commercial insurance enrollees and a substantial in-


flux of medical assistance patients. This places stress on the limited resources available in the smaller communities and possibly will not cover the costs of providing care to the expanded population.

L  arge health systems are absorbing more and more rural clinics and hospitals into their organizations. What impact do you see this having on the cost and quality of care in rural areas? Large systems are focused on market share rather than patient care. Large health systems enter rural communities and acquire small physician practices. This leads to fewer choices for patients, both in the primary care setting and the specialty care setting, as large systems refer to physicians they employ. As the large health systems gain market share, it leads to increased rates for consumers, insurance companies, and government payers because the large health system has great leverage with the payers. It is hard to negotiate with the only game in town. Large systems also tend to lose focus on the individual communities they serve. Often, patient care decisions are dictated from a management team at the system headquarters 100 miles away; it is presumed that all clinics and hospitals are the same. Clinics and hospitals should focus on the needs of their communities; not every community has the same challenges.  The best improvement potential and cost management occur at the independent provider level. Physicians who have a vested interest in their own practices have incentives at both the health outcome and the cost outcome levels. Improvement in both is best achieved with a change of culture, not a change of ownership. These physicians are not only able to apply change more

Cardiac Care at Saint Therese Strengthening the Heart for a Healthier Life Cardiac Care at Saint Therese offers: • Low rehospitalization rates. Only 11% of cardiac patients under our care readmit to the hospital, compared to the national average of 18% • Integrated programming connecting doctors, nurses, rehab specialists, clinical nutritionists and on-site pharmacists • Specially trained skilled nursing staff • Cardiac trained rehab professionals • On-site EKG equipment • Physician communication training • Four post-discharge phone call check-ins for a smooth transition to home SA I N T TH E R E S E of N E W H O P E

To learn more call 763.531.5028 or visit sttheresemn.org/cardiaccare

readily, but they also are usually more willing to do so. The impact we have seen has been a transition of the acquired hospital into a triage point for shipping patients to the parent organization’s city-based hospital. Among the clinics themselves, once acquired, we have seen hemorrhaging in the departure of the providers (seeming to run across the age spectrum) who were longtime members of the community.

W  here do you see the future of rural medicine in Minnesota going? Until recently it appeared the future of rural medicine was being usurped by large health systems where physicians were being replaced by mid-levels and community hospitals were being acquired for use as triage points before shipment to a metro area for care. We’re seeing a backlash in communities against this model as they realize they want and deserve care—and a voice—in their own community. We are returning to the days when providers actually looked at putting up their own shingle and practicing how and where they wanted. The number of calls we have received in this regard has been substantially higher in the past six months than in the previous couple of years. So the trend for larger systems to purchase rural clinics has led to dissatisfaction on the part of providers in those clinics, with the loss of autonomy in both clinical practice and administrative philosophy. Alternatively, there has been some success in integrating rural clinics with local, community hospitals. Perhaps a more palatable option for the independent providers who own their practices, both specialty and primary care, is to work in closer collaboration with local hospitals, but retain independence.

Providing SoluTionS To The unique inSurance needS of rural PhySicianS for over 125 yearS Independently owned with offices in Duluth, Hibbing, and Ashland. We understand the challenges of being a health care provider in outstate Minnesota.

We provide customized policies and highly personalized service in the fields of: • Medical Malpractice/ Tail Coverage • Property/ Liability/ Workers’ Comp • Personal insurance with umbrellas up to $20 Million • Financial Planning • Group Benifits For more information or to receive a no-cost insurance assessment please call Tom Stender 218-625-2120 • tstender@otismagie.com

www.otismagie.com 332 W Superior Street Suite 700 • Duluth, MN 55802

November 2013 Minnesota Physician

9


One team, one bill from cover

exceeded all expectations— and points the way toward the future of health care delivery. In June 2012, TCO launched a pilot for the Excel program. As of September 2013, the program had served 35 patients. The comprehensive program cares for patients having an outpatient total knee replacement, from pre-surgery through recovery post-surgery, all for one price. What sets the program apart from other approaches are two key components: comprehensive care and bundled payment. Integrated, comprehensive care A unique aspect of the Excel program is the comprehensive, all-inclusive nature of the care. Patients are supervised by a complete medical team—a surgeon, an internal medicine physician, and an orthopedic nurse

practitioner—with a shared goal of providing seamless, coordinated care. The Excel program is designed for young, healthy and active individuals who don’t have other serious medical issues that might require a hospital stay. We estimate that about 30 percent of all total

knee arthroplasty patients would be candidates for the program. (Patients requiring a higher level of care, such as a cardiology consult, would not be candidates for the Excel program.) After a patient is accepted into the program, a consulting nurse practitioner guides him or her through the

Cities Orthopedics, notes that this model allows the practice to “control what the nursing staff is doing at York Gardens, how the pre-operation teaching is done, how prepared the Currently, surgery takes patients are coming in to it, place at Twin Cities Orthopeand how the physical therapy dics’ Crosstown Surgery Center. is going to be done. All of the Four hours following surgery, nurses and therapists have been the patient is transported in trained by us, and we designed the clinical pathways What sets the program apart they follow. They spend time in the are two key components: surgery center so comprehensive care and they understand the entire patient bundled payment. experience. Everyone is on the same team.” a medi-van to nearby York entire experience, from the initial surgical consultation through aftercare in one of the program’s specially designed orthopedic recovery suites.

Gardens in Edina. There, the patient is taken to a private recovery suite equipped with many of the amenities of home, such as a flat-screen TV and a kitchenette. Caregivers and family are encouraged to visit at any time of day and are also welcomed to stay with the patient. Patients in the orthopedic recovery suites have 24-hour medical care; the surgeon, internal medicine physician, and program nurse practitioner make daily rounds. In addition, continuous care is provided by subspecialty trained orthopedic nurses and the rehabilitation facility is within steps of their suite.

FriedemannFoarde has been recognized as a Tier 1 Minneapolis health law firm by U.S. News-Best Lawyers for 2014.

“Our goal with Excel is for the patient to anticipate every single step,” says Justina Lehman-Lane, DNP, who oversees the program. “We want our patients to know what is coming next.” She ensures that every patient has her cellphone number, adding, “We’re like the small-town clinic.”

Kit Friedemann Mary Foarde 612.436.1020 • ffhealthlaw.com

The recovery suites are another innovative aspect of the Excel program. Though some surgical centers across the country outsource recovery to hotels, a hotel room can feel almost as impersonal as a hospital, and certainly doesn’t meet the sanitary qualifications or the on-site medical rehabilitation that the Excel program offers. Troy Simonson, CEO of Twin

10

Minnesota Physician November 2013

Sharelle Peterson, an athlete and knee replacement patient, says the Excel program was far more comforting and inviting than a hospital stay. “Being part of the Excel program, I was able to stay in a place where I didn’t feel sick. I was there because I was recovering. The environment was much more comfortable than the hospital, and I received assistance when I needed it much quicker than my hospital experiences in the past. I also saw my surgeon every day.” The financial model The bundled, all-inclusive price package for the Excel program also sets it apart from alternatives. In contrast to the traditional financial model, where a patient may receive eight to ten bills for a knee surgery, patients in the Excel program receive a single bill. And that one single bill covers the entire facility cost and health care team—surgeon, care team, and internal medicine doctors—that provides support, education, and care throughout the process. The bill also includes surgery and recovery costs, and as many physical therapy sessions as needed. The use of the dedicated orthopedic recovery suite, rather than in-hospital recovery, has reduced costs—by up to 50 percent in some cases—while elevating the patient experience. A traditional knee replacement One team, one bill to page 37


SALE!

INTRODUCTORY AHA

SE COMPLETE e Sale! nd After th a re fo e B —

WITH INTRODUCTORY

MA MA X! X!

CHRISTMAS! xperts RVICE by E

ine of L e r i t n E the Featuring

MA

ALL ALL

O

itu of Hom Furn t s a E k c lo b Just one • Suite 60 d a o LAY-AWAY R anos! n o s PiFOR d 7730 Hu

PIA M A YPRICES! U N MWITH AHA PTIAHE A T ED TO YSPECIAL

D IS C

LAY-AWAY FOR PRE-HOLIDAY CHRISTMAS! re

SPECIAL

X!

PRE-HOLIDAY

WITH

S S NO NO

N I N E P NOW O Store SALE! ! Y d l R r o W U o n B a i P D w e OO NW SALE! N I e r o t N S E d l P r o O W o n W a OPi ew NN N I ! N Y E R P O U W B O D N ! WOO

ALL

LAY-AWAY FOR CHRISTMAS!

AHA PIA M YA

S NO

e r o t S d l r o W o n a i P w e N

PRE-HOLIDAY

Y R U B D O WO

O O D IS C D IS C

SPECIAL PRICES! Yamaha Disklavier INTRODUCTORY Yamaha Yamaha NEW Yamaha Yamaha m Furniture o H E f o U t s a E k bloc e n H o N t s u J Clavinovas Hybrid Pianos Studios Grands 0 ite 6 TE D T O T PRICES! n Road • Su Pianos! 7730 Hudso

s f rnituLreETE SERVICE by Expert U u o F m e o n H E i f o L t COMP tiree 60 Just one block Eas n E r the Sale! H e N ft e A h d t n a g T T E D Yamaha — BeforePianos! TO Featur7i7n30 Hudson Road • Suit s rt Disklavier E by Expe NEW Yamaha Yamaha Yamaha of e Yamaha n i ETE SERVIC L L P ! e M r le O i a C t S e e En Clavinovas d After th Pianos Studios anHybrid — Before Yamaha aturing th Come FeGrands Learn about 24/7 Combining acoustic Leading choice in and see all the New Yamaha Grands starting from just Yamaha $ 99 Grands

4,299

Fun Easy Play features — Yamaha anyone can learn to play Clavinovas in just minutes!

for educational, Yamaha professional and forStudios home pianists.

grand action Yamaha NEW and concert Hybrid Pianos grand sound.

streaming radio play Disklavier and the latest player piano features!

TRADE-INS WELCOME! • ALL CREDIT CARDS ACCEPTED • DELIVERY & FINANCING AVAILABLE!

No one will giveCome youinmore forLeading yourchoice money! and see piano all the

Learn about 24/7 Combining acoustic streaming radio play grand action for educational, Fun Easy Play features — and the latest player and concert professional and anyone can learn to play piano features! grand sound. for home pianists. in just minutes! Learn about 24/7 Combining acoustic Leading choice Come in and see all the New Yamaha Grands 7730 Hudson Road •Fun Suite 60Play features 13810 24th Ave. N. radio play grand & action for educational, Easy — TRADE-INS CREDIT CARDS ACCEPTED • DELIVERY FINANCINGstreaming AVAILABLE! starting from just WELCOME! • ALLS.E. JUST 1 BLOCK EAST OF HOM FURNITURE OF HWY 55professional & I-494 • 1 BLK S. OFand BEST WESTERN and the latest player and concert anyone can learn CORNER to play $ 99 piano features! grand sound. for home pianists. in just minutes! Store also in ALEXANDRIA • 320-763-4011 901your Broadway St. Trusted in Minnesota for Over 60 Years! No one will give you more piano •for money! New Yamaha Grands starting from just $ 99

WOODBURY

4,299 651-730-7000

PLYMOUTH

763-533-6117

4,299

TRADE-INS WELCOME! •WWW.PIANOWORLD.NET ALL CREDIT CARDS ACCEPTED • DELIVERY & FINANCING AVAILABLE! Open 7 Days a Week! Open Weeknights Until 8pm! WOODBURY PLYMOUTH

No651-730-7000 one will give you more piano for your money! 763-533-6117 7730 Hudson Road • Suite 60

WOODBURY JUST 1 BLOCK EAST OF HOM FURNITURE

13810 24th Ave. N.

PLYMOUTH

S.E. CORNER OF HWY 55 & I-494 • 1 BLK S. OF BEST WESTERN

Store also in ALEXANDRIA • 320-763-4011 • 901 Broadway St. 651-730-7000 763-533-6117 7730 Hudson Road • Suite 60 13810 24th Ave. N.

Trusted in Minnesota for Over 60 Years!

Store also in ALEXANDRIA • 320-763-4011 • 901 Broadway St.

Trusted in Minnesota for Over 60 Years!

JUST 7 1 BLOCK EAST OFa HOM FURNITURE S.E. CORNER OF HWY 55 & I-494 • 1 BLK S. OF BEST WESTERN Open Days Week! WWW.PIANOWORLD.NET Open Weeknights Until 8pm!

Open 7 Days a Week! WWW.PIANOWORLD.NET Open Weeknights Until 8pm!

November 2013 Minnesota Physician

11


Screening for risky substance use from cover

plement this integrated, care manager model (elements of DIAMOND plus SBIRT). Since these clinics had extensive experience with DIAMOND, a key focus of the grant work in Minnesota was to determine the impact of adding substance use to the care model. Interest in the SBIRT program SBIRT is an early intervention designed to provide screening, brief behavior change interventions using motivational interviewing, and referral to formal addiction treatment when needed. Clinics added SBIRT for several reasons: • Minnesota ranks sixth nationally for binge drinking. • Risky alcohol and drug use are among the top four contributors to chronic diseases.

• Care managers see a high incidence of risky substance use in patients with depression. • Many of the clinics already had established a care management-based model. A DIAMOND care team is composed of the primary care physician; a care manager who regularly contacts the patient and coordinates their care; and a consulting psychiatrist who works with the care manager and recommends changes for patients not improving. • Clinics wanted to determine how handling multiple behavioral health conditions would affect patient care and care manager productivity. “The main benefit of screening for risky substance behaviors is to prevent patients from getting chronic illnesses such as cardiovascular disease, can-

cer, and diabetes,” said Mark Bixby, MD, North Memorial Health Care. “Through earlier identification, we can change a patient’s behavior before he or she becomes seriously ill.” For Kristin Somers, MD, a psychiatrist at Mayo Clinic, combining elements of SBIRT

and DIAMOND fit with Mayo’s desire to be innovative in integrating behavioral health into primary care. “Adding this component enhances our health care home and makes our clinic unique,” she said. Implementation With the integrated model, patients typically are screened before they see their physician. The PHQ-9 (Patient Health Questionnaire—nine questions) is used to identify depression, while the Alcohol Use Disorders Identification Test (AUDIT) or Drug Abuse Screening Test (DAST-10) is used to screen for alcohol or drug use.

The care manager provides routine follow-up to repeat the PHQ-9 and enters the patient’s data each time into a registry. Using the registry, the consulting psychiatrist and the care manager review a patient’s progress each week. If a patient is not improving, the psychiatrist might recommend a change to treatment. The care manager relays the recommendation to the primary care physician, who has ultimate Minnesota Physician November 2013

Screening for substance use indicates if a patient is at low, medium, or high risk. Most receive a brief intervention in

Clinics indicated that the factors making depression care successful in primary care also apply to risky substance use treatment.

If a patient is positive for one or more of these conditions, the primary care physician is informed. He or she recommends the appropriate care plan and introduces the patient to a care manager, who typically has a background in nursing, social work, psychology, or as certified medical assistants. The care manager becomes the patient’s primary contact for education, care coordination, and follow-up.

12

responsibility for the care plan. Roughly 30 percent of patients with depression receiving this type of care are in remission by six months.

which the care manager educates the patient on the health risks and uses motivational interviewing to help the patient set goals for behavioral change. If a patient has possible abuse or dependence issues, he or she is referred to additional resources. Changing roles and workflow “Adding screening for substance use increased the work for our DIAMOND care managers,” said Mary Lou Oman, RN, psychiatric nurse consultant, who helps to oversee 15 care managers for Entira Family Clinics. Although care managers find their caseloads need to be decreased in order to address multiple conditions, physicians support the additional screening, and management for substance misuse. “Our traditional care has almost been hyphenated by the requirements of time,” said Jeffrey Virant, MD, Stillwater Medical Group. “We acknowledge that an illness has stolen the patient’s motivation and hope, and yet we give them a pill and say, ‘Call us in four weeks.’ We lose a lot of patients at that point. Now, I rely on my care manager to help the patient put one foot in front of the other. This is really valuable.” Challenges and lessons learned There are challenges to implementing the integrated model, but participating clinics are learning how to address them Screening for risky substance use to page 36


B:8.625” T:7.75” S:7”

PROVEN. LOW RATE OF HYPOGLYCEMIA

POWERFUL A1C REDUCTIONS -0.8% to -1.5%*

MAY PROVIDE ADDITIONAL BENEFIT OF WEIGHT LOSS†

For adult patients with type 2 diabetes, Victoza® offers these benefits and more. Visit VictozaPro.com/Care to learn how the support program helps patients get started.

*Victoza® 1.2 mg and 1.8 mg when used alone or in combination with OADs. † Victoza® is not indicated for the management of obesity, and weight change was a secondary end point in clinical trials.

Liraglutide causes dose-dependent and treatment-durationdependent thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice. It is unknown whether Victoza® causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as human relevance could not be ruled out by clinical or nonclinical studies. Victoza® is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Based on the findings in rodents, monitoring with serum calcitonin or thyroid ultrasound was performed during clinical trials, but this may have increased the number of unnecessary thyroid surgeries. It is unknown whether monitoring with serum calcitonin or thyroid ultrasound will mitigate Victoza® is a registered trademark of Novo Nordisk A/S. © 2013 Novo Nordisk All rights reserved.

human risk of thyroid C-cell tumors. Patients should be counseled regarding the risk and symptoms of thyroid tumors. Do not use in patients with a prior serious hypersensitivity reaction to Victoza® (liraglutide [rDNA origin] injection) or to any of the product components. Postmarketing reports, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. Discontinue promptly if pancreatitis is suspected. Do not restart if pancreatitis is confirmed. Consider other antidiabetic therapies in patients with a history of pancreatitis. When Victoza® is used with an insulin secretagogue (e.g. a sulfonylurea) or insulin serious hypoglycemia can occur. Consider lowering the dose of the insulin secretagogue or insulin to reduce the risk of hypoglycemia. Renal impairment has been reported postmarketing, usually in association with nausea, vomiting, diarrhea, or dehydration which may sometimes require hemodialysis. Use caution when initiating or escalating doses of Victoza® in patients with renal impairment. Serious hypersensitivity reactions (e.g. anaphylaxis and angioedema) have been reported during postmarketing use of Victoza®. If symptoms of hypersensitivity reactions occur, patients must stop taking Victoza® and seek medical advice promptly. There have been no studies establishing conclusive evidence of macrovascular risk reduction with Victoza® or any other antidiabetic drug. The most common adverse reactions, reported in ≥5% of patients treated with Victoza® and more commonly than in patients treated with placebo, are headache, nausea, diarrhea, dyspepsia, constipation and antiliraglutide antibody formation. Immunogenicity-related events, including urticaria, were more common among Victoza®-treated patients (0.8%) than among comparator-treated patients (0.4%) in clinical trials. Victoza® has not been studied in type 2 diabetes patients below 18 years of age and is not recommended for use in pediatric patients. There is limited data in patients with renal or hepatic impairment. Please see brief summary of Prescribing Information on adjacent page.

0513-00015590-1

June 2013

November 2013 Minnesota Physician VICU3X1334_ISI_Update_A_Size_Ad_r6.indd 1

5/31/13 12:47 PM

13

B:11.125”

Important Safety Information

S:10”

Victoza® (liraglutide [rDNA origin] injection) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Because of the uncertain relevance of the rodent thyroid C-cell tumor findings to humans, prescribe Victoza® only to patients for whom the potential benefits are considered to outweigh the potential risk. Victoza® is not recommended as first-line therapy for patients who have inadequate glycemic control on diet and exercise. Based on spontaneous postmarketing reports, acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis has been observed in patients treated with Victoza®. Victoza® has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for pancreatitis while using Victoza®. Other antidiabetic therapies should be considered in patients with a history of pancreatitis. Victoza® is not a substitute for insulin. Victoza® should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. Victoza® has not been studied in combination with prandial insulin.

T:10.5”

Indications and Usage


Victoza® (liraglutide [rDNA origin] injection) Rx Only BRIEF SUMMARY. Please consult package insert for full prescribing information. WARNING: RISK OF THYROID C-CELL TUMORS: Liraglutide causes dose-dependent and treatmentduration-dependent thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice. It is unknown whether Victoza® causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as human relevance could not be ruled out by clinical or nonclinical studies. Victoza® is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Based on the findings in rodents, monitoring with serum calcitonin or thyroid ultrasound was performed during clinical trials, but this may have increased the number of unnecessary thyroid surgeries. It is unknown whether monitoring with serum calcitonin or thyroid ultrasound will mitigate human risk of thyroid C-cell tumors. Patients should be counseled regarding the risk and symptoms of thyroid tumors [see Contraindications and Warnings and Precautions]. INDICATIONS AND USAGE: Victoza® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Important Limitations of Use: Because of the uncertain relevance of the rodent thyroid C-cell tumor findings to humans, prescribe Victoza® only to patients for whom the potential benefits are considered to outweigh the potential risk. Victoza® is not recommended as first-line therapy for patients who have inadequate glycemic control on diet and exercise. Based on spontaneous postmarketing reports, acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis has been observed in patients treated with Victoza®. Victoza® has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for pancreatitis while using Victoza®. Other antidiabetic therapies should be considered in patients with a history of pancreatitis. Victoza® is not a substitute for insulin. Victoza® should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. The concurrent use of Victoza® and prandial insulin has not been studied. CONTRAINDICATIONS: Do not use in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use in patients with a prior serious hypersensitivity reaction to Victoza® or to any of the product components. WARNINGS AND PRECAUTIONS: Risk of Thyroid C-cell Tumors: Liraglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors (adenomas and/or carcinomas) at clinically relevant exposures in both genders of rats and mice. Malignant thyroid C-cell carcinomas were detected in rats and mice. A statistically significant increase in cancer was observed in rats receiving liraglutide at 8-times clinical exposure compared to controls. It is unknown whether Victoza® will cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors could not be determined by clinical or nonclinical studies. In the clinical trials, there have been 6 reported cases of thyroid C-cell hyperplasia among Victoza®-treated patients and 2 cases in comparator-treated patients (1.3 vs. 1.0 cases per 1000 patient-years). One comparator-treated patient with MTC had pre-treatment serum calcitonin concentrations >1000 ng/L suggesting pre-existing disease. All of these cases were diagnosed after thyroidectomy, which was prompted by abnormal results on routine, protocol-specified measurements of serum calcitonin. Five of the six Victoza®-treated patients had elevated calcitonin concentrations at baseline and throughout the trial. One Victoza® and one non-Victoza®-treated patient developed elevated calcitonin concentrations while on treatment. Calcitonin, a biological marker of MTC, was measured throughout the clinical development program. The serum calcitonin assay used in the Victoza® clinical trials had a lower limit of quantification (LLOQ) of 0.7 ng/L and the upper limit of the reference range was 5.0 ng/L for women and 8.4 ng/L for men. At Weeks 26 and 52 in the clinical trials, adjusted mean serum calcitonin concentrations were higher in Victoza®-treated patients compared to placebo-treated patients but not compared to patients receiving active comparator. At these timepoints, the adjusted mean serum calcitonin values (~1.0 ng/L) were just above the LLOQ with between-group differences in adjusted mean serum calcitonin values of approximately 0.1 ng/L or less. Among patients with pre-treatment serum calcitonin below the upper limit of the reference range, shifts to above the upper limit of the reference range which persisted in subsequent measurements occurred most frequently among patients treated with Victoza® 1.8 mg/day. In trials with on-treatment serum calcitonin measurements out to 5-6 months, 1.9% of patients treated with Victoza® 1.8 mg/day developed new and persistent calcitonin elevations above the upper limit of the reference range compared to 0.8-1.1% of patients treated with control medication or the 0.6 and 1.2 mg doses of Victoza®. In trials with on-treatment serum calcitonin measurements out to 12 months, 1.3% of patients treated with Victoza® 1.8 mg/day had new and persistent elevations of calcitonin from below or within the reference range to above the upper limit of the reference range, compared to 0.6%, 0% and 1.0% of patients treated with Victoza® 1.2 mg, placebo and active control, respectively. Otherwise, Victoza® did not produce consistent dose-dependent or time-dependent increases in serum calcitonin. Patients with MTC usually have calcitonin values >50 ng/L. In Victoza® clinical trials, among patients with pre-treatment serum calcitonin <50 ng/L, one Victoza®-treated patient and no comparator-treated patients developed serum calcitonin >50 ng/L. The Victoza®-treated patient who developed serum calcitonin >50 ng/L had an elevated pre-treatment serum calcitonin of 10.7 ng/L that increased to 30.7 ng/L at Week 12 and 53.5 ng/L at the end of the 6-month trial. Follow-up serum calcitonin was 22.3 ng/L more than 2.5 years after the last dose of Victoza®. The largest increase in serum calcitonin in a comparator-treated patient was seen with glimepiride in a patient whose serum calcitonin increased from 19.3 ng/L at baseline to 44.8 ng/L at Week 65 and 38.1 ng/L at Week 104. Among patients who began with serum calcitonin <20 ng/L, calcitonin elevations to >20 ng/L occurred in 0.7% of Victoza®-treated patients, 0.3% of placebo-treated patients, and 0.5% of active-comparator-treated patients, with an incidence of 1.1% among patients treated with 1.8 mg/day of Victoza®. The clinical significance of these findings is unknown. Counsel patients regarding the risk for MTC and the symptoms of thyroid tumors (e.g. a mass in the neck, dysphagia, dyspnea or persistent hoarseness). It is unknown whether monitoring with serum calcitonin or thyroid ultrasound will mitigate the potential risk of MTC, and such monitoring may increase the risk of unnecessary procedures, due to low test specificity for serum calcitonin and a high background incidence of thyroid disease. Patients with thyroid nodules noted on physical examination or neck imaging obtained for other reasons should be referred to an endocrinologist for further evaluation. Although routine monitoring of serum calcitonin is of uncertain value in patients treated with Victoza®, if serum calcitonin is measured and found to be elevated, the patient should be referred to an endocrinologist for further evaluation. Pancreatitis: Based on spontaneous postmarketing reports, acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with Victoza®. After initiation of Victoza®, observe patients carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back and which may or may not be accompanied by vomiting). If pancreatitis is suspected, Victoza® should promptly be discontinued and appropriate management should be initiated. If pancreatitis is confirmed, Victoza® should not be restarted. Consider antidiabetic therapies other than Victoza® in patients with a history of pancreatitis. In clinical trials of Victoza®, there have been 13 cases of pancreatitis among Victoza®-treated patients and 1 case in a comparator (glimepiride) treated patient (2.7 vs. 0.5 cases per 1000 patient-years). Nine of the 13 cases with Victoza® were reported as acute pancreatitis and four were reported as chronic pancreatitis. In one case in a Victoza®-treated patient, pancreatitis, with necrosis, was observed and led to death; however clinical causal-

14

ity could not be established. Some patients had other risk factors for pancreatitis, such as a history of cholelithiasis or alcohol abuse. Use with Medications Known to Cause Hypoglycemia: Patients receiving Victoza® in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia. The risk of hypoglycemia may be lowered by a reduction in the dose of sulfonylurea (or other concomitantly administered insulin secretagogues) or insulin Renal Impairment: Victoza® has not been found to be directly nephrotoxic in animal studies or clinical trials. There have been postmarketing reports of acute renal failure and worsening of chronic renal failure, which may sometimes require hemodialysis in Victoza®-treated patients. Some of these events were reported in patients without known underlying renal disease. A majority of the reported events occurred in patients who had experienced nausea, vomiting, diarrhea, or dehydration. Some of the reported events occurred in patients receiving one or more medications known to affect renal function or hydration status. Altered renal function has been reversed in many of the reported cases with supportive treatment and discontinuation of potentially causative agents, including Victoza®. Use caution when initiating or escalating doses of Victoza® in patients with renal impairment. Hypersensitivity Reactions: There have been postmarketing reports of serious hypersensitivity reactions (e.g., anaphylactic reactions and angioedema) in patients treated with Victoza®. If a hypersensitivity reaction occurs, the patient should discontinue Victoza® and other suspect medications and promptly seek medical advice. Angioedema has also been reported with other GLP-1 receptor agonists. Use caution in a patient with a history of angioedema with another GLP-1 receptor agonist because it is unknown whether such patients will be predisposed to angioedema with Victoza®. Macrovascular Outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Victoza® or any other antidiabetic drug. ADVERSE REACTIONS: Clinical Trials Experience: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety of Victoza® has been evaluated in 8 clinical trials: A double-blind 52-week monotherapy trial compared Victoza® 1.2 mg daily, Victoza® 1.8 mg daily, and glimepiride 8 mg daily; A double-blind 26 week add-on to metformin trial compared Victoza® 0.6 mg once-daily, Victoza® 1.2 mg once-daily, Victoza® 1.8 mg once-daily, placebo, and glimepiride 4 mg once-daily; A double-blind 26 week add-on to glimepiride trial compared Victoza® 0.6 mg daily, Victoza® 1.2 mg once-daily, Victoza® 1.8 mg once-daily, placebo, and rosiglitazone 4 mg once-daily; A 26 week add-on to metformin + glimepiride trial, compared double-blind Victoza® 1.8 mg once-daily, double-blind placebo, and open-label insulin glargine once-daily; A doubleblind 26-week add-on to metformin + rosiglitazone trial compared Victoza® 1.2 mg once-daily, Victoza® 1.8 mg once-daily and placebo; An open-label 26-week add-on to metformin and/or sulfonylurea trial compared Victoza® 1.8 mg once-daily and exenatide 10 mcg twice-daily; An open-label 26-week add-on to metformin trial compared Victoza® 1.2 mg once-daily, Victoza® 1.8 mg once-daily, and sitagliptin 100 mg once-daily; An open-label 26-week trial compared insulin detemir as add-on to Victoza® 1.8 mg + metformin to continued treatment with Victoza® + metformin alone. Withdrawals: The incidence of withdrawal due to adverse events was 7.8% for Victoza®-treated patients and 3.4% for comparator-treated patients in the five double-blind controlled trials of 26 weeks duration or longer. This difference was driven by withdrawals due to gastrointestinal adverse reactions, which occurred in 5.0% of Victoza®-treated patients and 0.5% of comparator-treated patients. In these five trials, the most common adverse reactions leading to withdrawal for Victoza®-treated patients were nausea (2.8% versus 0% for comparator) and vomiting (1.5% versus 0.1% for comparator). Withdrawal due to gastrointestinal adverse events mainly occurred during the first 2-3 months of the trials. Common adverse reactions: Tables 1, 2, 3 and 4 summarize common adverse reactions (hypoglycemia is discussed separately) reported in seven of the eight controlled trials of 26 weeks duration or longer. Most of these adverse reactions were gastrointestinal in nature. In the five double-blind clinical trials of 26 weeks duration or longer, gastrointestinal adverse reactions were reported in 41% of Victoza®-treated patients and were dose-related. Gastrointestinal adverse reactions occurred in 17% of comparator-treated patients. Common adverse reactions that occurred at a higher incidence among Victoza®-treated patients included nausea, vomiting, diarrhea, dyspepsia and constipation. In the five double-blind and three open-label clinical trials of 26 weeks duration or longer, the percentage of patients who reported nausea declined over time. In the five double-blind trials approximately 13% of Victoza®-treated patients and 2% of comparator-treated patients reported nausea during the first 2 weeks of treatment. In the 26-week open-label trial comparing Victoza® to exenatide, both in combination with metformin and/or sulfonylurea, gastrointestinal adverse reactions were reported at a similar incidence in the Victoza® and exenatide treatment groups (Table 3). In the 26-week open-label trial comparing Victoza® 1.2 mg, Victoza® 1.8 mg and sitagliptin 100 mg, all in combination with metformin, gastrointestinal adverse reactions were reported at a higher incidence with Victoza® than sitagliptin (Table 4). In the remaining 26-week trial, all patients received Victoza® 1.8 mg + metformin during a 12-week run-in period. During the run-in period, 167 patients (17% of enrolled total) withdrew from the trial: 76 (46% of withdrawals) of these patients doing so because of gastrointestinal adverse reactions and 15 (9% of withdrawals) doing so due to other adverse events. Only those patients who completed the run-in period with inadequate glycemic control were randomized to 26 weeks of add-on therapy with insulin detemir or continued, unchanged treatment with Victoza® 1.8 mg + metformin. During this randomized 26-week period, diarrhea was the only adverse reaction reported in ≥5% of patients treated with Victoza® 1.8 mg + metformin + insulin detemir (11.7%) and greater than in patients treated with Victoza® 1.8 mg and metformin alone (6.9%). Table 1: Adverse reactions reported in ≥5% of Victoza®-treated patients in a 52-week monotherapy trial All Victoza® N = 497 Glimepiride N = 248 (%) (%) Adverse Reaction Nausea 28.4 8.5 Diarrhea 17.1 8.9 Vomiting 10.9 3.6 Constipation 9.9 4.8 Headache 9.1 9.3 Table 2: Adverse reactions reported in ≥5% of Victoza®-treated patients and occurring more frequently with Victoza® compared to placebo: 26-week combination therapy trials Add-on to Metformin Trial All Victoza® + Metformin Placebo + Metformin Glimepiride + Metformin N = 724 N = 121 N = 242 (%) (%) (%) Adverse Reaction Nausea 15.2 4.1 3.3 Diarrhea 10.9 4.1 3.7 Headache 9.0 6.6 9.5 Vomiting 6.5 0.8 0.4 Add-on to Glimepiride Trial Placebo + Glimepiride Rosiglitazone + All Victoza® + Glimepiride N = 695 N = 114 Glimepiride N = 231 (%) (%) (%) Adverse Reaction Nausea 7.5 1.8 2.6 Diarrhea 7.2 1.8 2.2

Minnesota Physician November 2013 VICU3X1334_ISI_Update_A_Size_Ad_BS_r6.indd 1

5/31/13 12:48 PM


Constipation Dyspepsia

5.3 0.9 1.7 5.2 0.9 2.6 Add-on to Metformin + Glimepiride Victoza® 1.8 + Metformin Placebo + Metformin + Glargine + Metformin + + Glimepiride N = 230 Glimepiride N = 114 Glimepiride N = 232 (%) (%) (%) Adverse Reaction Nausea 13.9 3.5 1.3 Diarrhea 10.0 5.3 1.3 Headache 9.6 7.9 5.6 Dyspepsia 6.5 0.9 1.7 Vomiting 6.5 3.5 0.4 Add-on to Metformin + Rosiglitazone ® Placebo + Metformin + Rosiglitazone All Victoza + Metformin + Rosiglitazone N = 355 N = 175 (%) (%) Adverse Reaction Nausea 34.6 8.6 Diarrhea 14.1 6.3 Vomiting 12.4 2.9 Headache 8.2 4.6 Constipation 5.1 1.1 Table 3: Adverse Reactions reported in ≥5% of Victoza®-treated patients in a 26-Week Open-Label Trial versus Exenatide Victoza® 1.8 mg once daily + Exenatide 10 mcg twice daily + metformin and/or sulfonylurea metformin and/or sulfonylurea N = 235 N = 232 (%) (%) Adverse Reaction Nausea 25.5 28.0 Diarrhea 12.3 12.1 Headache 8.9 10.3 Dyspepsia 8.9 4.7 Vomiting 6.0 9.9 Constipation 5.1 2.6 Table 4: Adverse Reactions in ≥5% of Victoza®-treated patients in a 26-Week Open-Label Trial versus Sitagliptin All Victoza® + metformin Sitagliptin 100 mg/day + N = 439 metformin N = 219 (%) (%) Adverse Reaction Nausea 23.9 4.6 Headache 10.3 10.0 Diarrhea 9.3 4.6 Vomiting 8.7 4.1 Immunogenicity: Consistent with the potentially immunogenic properties of protein and peptide pharmaceuticals, patients treated with Victoza® may develop anti-liraglutide antibodies. Approximately 50-70% of Victoza®-treated patients in the five double-blind clinical trials of 26 weeks duration or longer were tested for the presence of anti-liraglutide antibodies at the end of treatment. Low titers (concentrations not requiring dilution of serum) of anti-liraglutide antibodies were detected in 8.6% of these Victoza®-treated patients. Sampling was not performed uniformly across all patients in the clinical trials, and this may have resulted in an underestimate of the actual percentage of patients who developed antibodies. Cross-reacting antiliraglutide antibodies to native glucagon-like peptide-1 (GLP-1) occurred in 6.9% of the Victoza®-treated patients in the double-blind 52-week monotherapy trial and in 4.8% of the Victoza®-treated patients in the double-blind 26-week add-on combination therapy trials. These cross-reacting antibodies were not tested for neutralizing effect against native GLP-1, and thus the potential for clinically significant neutralization of native GLP-1 was not assessed. Antibodies that had a neutralizing effect on liraglutide in an in vitro assay occurred in 2.3% of the Victoza®-treated patients in the double-blind 52-week monotherapy trial and in 1.0% of the Victoza®-treated patients in the double-blind 26-week add-on combination therapy trials. Among Victoza®-treated patients who developed anti-liraglutide antibodies, the most common category of adverse events was that of infections, which occurred among 40% of these patients compared to 36%, 34% and 35% of antibody-negative Victoza®-treated, placebo-treated and active-control-treated patients, respectively. The specific infections which occurred with greater frequency among Victoza®-treated antibody-positive patients were primarily nonserious upper respiratory tract infections, which occurred among 11% of Victoza®-treated antibody-positive patients; and among 7%, 7% and 5% of antibody-negative Victoza®-treated, placebo-treated and active-control-treated patients, respectively. Among Victoza®-treated antibody-negative patients, the most common category of adverse events was that of gastrointestinal events, which occurred in 43%, 18% and 19% of antibody-negative Victoza®-treated, placebo-treated and active-control-treated patients, respectively. Antibody formation was not associated with reduced efficacy of Victoza® when comparing mean HbA1c of all antibody-positive and all antibody-negative patients. However, the 3 patients with the highest titers of anti-liraglutide antibodies had no reduction in HbA1c with Victoza® treatment. In the five double-blind clinical trials of Victoza®, events from a composite of adverse events potentially related to immunogenicity (e.g. urticaria, angioedema) occurred among 0.8% of Victoza®-treated patients and among 0.4% of comparator-treated patients. Urticaria accounted for approximately one-half of the events in this composite for Victoza®-treated patients. Patients who developed anti-liraglutide antibodies were not more likely to develop events from the immunogenicity events composite than were patients who did not develop anti-liraglutide antibodies. Injection site reactions: Injection site reactions (e.g., injection site rash, erythema) were reported in approximately 2% of Victoza®-treated patients in the five double-blind clinical trials of at least 26 weeks duration. Less than 0.2% of Victoza®-treated patients discontinued due to injection site reactions. Papillary thyroid carcinoma: In clinical trials of Victoza®, there were 7 reported cases of papillary thyroid carcinoma in patients treated with Victoza® and 1 case in a comparator-treated patient (1.5 vs. 0.5 cases per 1000 patient-years). Most of these papillary thyroid carcinomas were <1 cm in greatest diameter and were diagnosed in surgical pathology specimens after thyroidectomy prompted by findings on protocol-specified screening with serum calcitonin or thyroid ultrasound. Hypoglycemia: In the eight clinical trials of at least 26 weeks duration, hypoglycemia requiring the assistance of another person for treatment occurred in 11 Victoza®-treated patients (2.3 cases per 1000 patient-years) and in two exenatidetreated patients. Of these 11 Victoza®-treated patients, six patients were concomitantly using metformin and a sulfonylurea, one was concomitantly using a sulfonylurea, two were concomitantly using metformin (blood glucose values were 65 and 94 mg/dL) and two were using Victoza® as monotherapy (one of these patients was undergoing an intravenous glucose tolerance test and the other was receiving insulin as treatment during a hospital stay). For these two patients on Victoza® monotherapy, the insulin treatment was the likely explanation for the hypoglycemia. In the 26-week open-label trial comparing Victoza® to sitagliptin,

VICU3X1334_ISI_Update_A_Size_Ad_BS_r6.indd 2

the incidence of hypoglycemic events defined as symptoms accompanied by a fingerstick glucose <56 mg/ dL was comparable among the treatment groups (approximately 5%). Table 5: Incidence (%) and Rate (episodes/patient year) of Hypoglycemia in the 52-Week Monotherapy Trial and in the 26-Week Combination Therapy Trials Victoza® Treatment Active Comparator Placebo Comparator None Monotherapy Victoza® (N = 497) Glimepiride (N = 248) Patient not able to 0 0 — self−treat Patient able to self−treat 9.7 (0.24) 25.0 (1.66) — Not classified 1.2 (0.03) 2.4 (0.04) — ® Glimepiride + Placebo + Metformin Add-on to Metformin Victoza + Metformin (N = 724) Metformin (N = 121) (N = 242) Patient not able to 0.1 (0.001) 0 0 self−treat Patient able to self−treat 3.6 (0.05) 22.3 (0.87) 2.5 (0.06) Continued Victoza® None Add-on to Victoza® + Insulin detemir + Metformin Victoza® + Metformin + Metformin alone (N = 163) (N = 158*) 0 0 — Patient not able to self−treat Patient able to self−treat 9.2 (0.29) 1.3 (0.03) — Add-on to Victoza® + Glimepiride Rosiglitazone + Placebo + Glimepiride (N = 695) Glimepiride (N = 231) (N = 114) Glimepiride Patient not able to 0.1 (0.003) 0 0 self−treat Patient able to self−treat 7.5 (0.38) 4.3 (0.12) 2.6 (0.17) Not classified 0.9 (0.05) 0.9 (0.02) 0 Placebo + Metformin Add-on to Metformin Victoza® + Metformin + Rosiglitazone None + Rosiglitazone + Rosiglitazone (N = 355) (N = 175) 0 — 0 Patient not able to self−treat Patient able to self−treat 7.9 (0.49) — 4.6 (0.15) Not classified 0.6 (0.01) — 1.1 (0.03) Add-on to Metformin Victoza® + Metformin Insulin glargine Placebo + Metformin + Glimepiride + Metformin + + Glimepiride + Glimepiride (N = 230) Glimepiride (N = 232) (N = 114) Patient not able to 2.2 (0.06) 0 0 self−treat Patient able to self−treat 27.4 (1.16) 28.9 (1.29) 16.7 (0.95) Not classified 0 1.7 (0.04) 0 *One patient is an outlier and was excluded due to 25 hypoglycemic episodes that the patient was able to self-treat. This patient had a history of frequent hypoglycemia prior to the study. In a pooled analysis of clinical trials, the incidence rate (per 1,000 patient-years) for malignant neoplasms (based on investigator-reported events, medical history, pathology reports, and surgical reports from both blinded and open-label study periods) was 10.9 for Victoza®, 6.3 for placebo, and 7.2 for active comparator. After excluding papillary thyroid carcinoma events [see Adverse Reactions], no particular cancer cell type predominated. Seven malignant neoplasm events were reported beyond 1 year of exposure to study medication, six events among Victoza®-treated patients (4 colon, 1 prostate and 1 nasopharyngeal), no events with placebo and one event with active comparator (colon). Causality has not been established. Laboratory Tests: In the five clinical trials of at least 26 weeks duration, mildly elevated serum bilirubin concentrations (elevations to no more than twice the upper limit of the reference range) occurred in 4.0% of Victoza®treated patients, 2.1% of placebo-treated patients and 3.5% of active-comparator-treated patients. This finding was not accompanied by abnormalities in other liver tests. The significance of this isolated finding is unknown. Vital signs: Victoza® did not have adverse effects on blood pressure. Mean increases from baseline in heart rate of 2 to 3 beats per minute have been observed with Victoza® compared to placebo. The long-term clinical effects of the increase in pulse rate have not been established. Post-Marketing Experience: The following additional adverse reactions have been reported during post-approval use of Victoza®. Because these events are reported voluntarily from a population of uncertain size, it is generally not possible to reliably estimate their frequency or establish a causal relationship to drug exposure: Dehydration resulting from nausea, vomiting and diarrhea; Increased serum creatinine, acute renal failure or worsening of chronic renal failure, sometimes requiring hemodialysis; Angioedema and anaphylactic reactions; Allergic reactions: rash and pruritus; Acute pancreatitis, hemorrhagic and necrotizing pancreatitis sometimes resulting in death. OVERDOSAGE: Overdoses have been reported in clinical trials and post-marketing use of Victoza®. Effects have included severe nausea and severe vomiting. In the event of overdosage, appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms. More detailed information is available upon request. For information about Victoza® contact: Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ 08536, 1−877-484-2869 Date of Issue: April 16, 2013 Version: 6 Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark Victoza® is covered by US Patent Nos. 6,268,343, 6,458,924, 7,235,627, 8,114,833 and other patents pending. Victoza® Pen is covered by US Patent Nos. 6,004,297, RE 43,834, RE 41,956 and other patents pending. © 2010-2013 Novo Nordisk 0513-00015681-1 5/2013

November 2013 Minnesota Physician 5/31/13 12:48 PM

15


Models of care

T

Turning health programming inside out

he health care landscape is changing, and the need to deliver greater value in health care has never been more urgent. To deliver greater value, our clinical programming needs to evolve from the provider- and patient-centric models of the past and present, respectively, to a population-centric approach. Such an approach delivers higher value care by making a given population’s values the cornerstone of medical care programs. This article discusses key factors contributing to the current state of health care delivery; a proposed evolution in care delivery; an orthopedic population-centric quality initiative; and how physicians can accelerate the evolution to population-centric programming in their practices. Barriers to advancing health care delivery Four key factors contribute to the current barriers to improv-

A population-centric approach to “cost” and “quality” By Emily Karlen, MPT ing health care delivery. Unsustainable cost increases. According to CMS’ “National Health Expenditures Projections 2011–2021” report, total health care spending in the United States is expected to consume nearly 20 percent of our economy, or $4.8 trillion, by 2021, up from $2.6 trillion in 2010. Although the rate of increase has slowed in the past decade, it continues to be well above the rate of inflation. If the price of a dozen eggs in 1945

“As physicians, we have so many unknowns coming our way... One thing I am certain about is my malpractice protection.” Medicine is feeling the effects of regulatory and legislative changes, increasing risk, and profitability demands—all contributing to uncertainty and lack of control. What we do control as physicians: our choice of a liability partner. I selected ProAssurance because they stand behind my good medicine. In spite of the maelstrom, I am protected, respected, and heard. I believe in fair treatment—and I get it.

Professional Liability Insurance & Risk Management Services ProAssurance Group is rated A+ (Superior) by A.M. Best. ProAssurance.com • 800.282.6242

16

Minnesota Physician November 2013

had climbed at the same rate as health care costs, today those eggs would cost $55. Care resourced for revenue rather than value. In the quest for higher revenues, traditional fee-for-service reimbursement rewards both excessive and costly treatments. As an example, in 2009 Health Affairs journal reported that increases in medical practices’ ownership of MRI equipment are related to higher use of both MRIs and surgeries for people with low back pain (LBP). Additionally, specialist compensation often reflects the potential of a particular specialty to drive revenue; consequently, more providers are drawn into the high revenue–producing specialties. It is not surprising that back pain patients and their primary care providers often report having reasonable access to spine surgeons (whose average annual compensation is $688,503, according to the American Medical Group Association), but very limited access to psychologists (annual compensation of $68,640, according to the U.S. Bureau of Labor). Imbalances such as these do not meet the needs of the LBP population. Only 1 percent to 2 percent of people seeking medical care for LBP will have surgery, according to the American Academy of Orthopedic Surgeons, but up to 77 percent of people with chronic LBP also have a psychiatric diagnosis (excluding somatoform pain disorder), according to Spine journal. Inconsistent application of evidence-based best-practice medicine. Over the past decade, Health Affairs reports, just

over 50 percent of American and European medical practitioners followed care guidelines. Individuals will vary in clinical presentation, but evidence supports improved outcomes when guidelines are followed. Outdated expectations. Communities expect health care providers to deliver better health. In the latter half of the 20th century, this expectation was reasonable; physicians had conquered top causes of death such as pneumonia, tuberculosis, and diarrhea. However, since the late 1990s, at least 60 percent of all deaths are due to poor lifestyle choices, such as inactivity, poor diet, and smoking. When individual behaviors account for such a high percentage of our health, it is unreasonable to expect that health care providers alone will restore complete health. For that, we must look to the individual, with the support of the community, in partnership with health care providers. Evolution in care delivery Since doing “more of the same” will not lead to delivering higher value care, and some current health-care program strategies will not deliver higher value quickly enough, Fairview’s system-wide orthopedic programming has evolved to a population-centric approach. In delivering quality programming through this lens, many of our initiatives have been able to simultaneously deliver higher quality of care and better population health while also reducing the cost to the community. Many providers have already moved beyond the providercentric care model and into delivering patient-centric care. They acknowledge that providing access to health care requires extended evening and weekend office hours, and that some patients may want their care delivered in a retail store rather than a clinic. Population-centric programming requires us to look beyond the care we deliver to individual patients and consider new avenues for improving health


Figure 2. Low-back-pain population funnel. in a population. For example, seeing an opportunity to improve the health of its employee population, Fairview Physician Associates provided additional refrigerators so that employees could store healthy lunches rather than rely on the nearby fast-food restaurants. Financial goals also must shift in order to deliver higher value care. Past care models, based on fee-for-service reimbursement, would often focus financial goals on generating revenue (e.g., How many surgeries would have to be done in order hit a certain revenue target?). Following this model, spine surgeries were often financial drivers for hospitals. This approach, illustrated by the funnel in Figure 1, shows that to increase the health system’s surgical volume to 600 procedures would require a market share of 300,000 people.

comparable outcomes for many people with low back pain, the health system sees financial opportunity by noting the number of people with chronic low back pain and aiming to more quickly and effectively manage their symptoms, with the goal of preventing disability and any clinically inappropriate surgeries. This approach adds higher value care through improving quality outcomes and reducing cost. In population-centric programming, “cost” is defined as the community’s resources consumed when a service is delivered. It considers indirect costs, like lost work days, in addition to the community’s direct costs.

In addition to redefining cost, population-centric care requires redefining quality. Many existing care models define quality by safety or process measures that serve to meet regulatory needs. In population-centric programming, As reimbursement tightquality is measured by the ened over the years, health care systems began to focus more on population’s values. For many patients, safe care is assumed; reducing “costs,” defined as the the fundamental value of the care lies in being Figure 1. Low-back surgery funnel of the past. able to return to Low Back Cost Funnel: the lives they had before becoming ill or injured. 300,000 100,000 57,000 36,000 600 People with LBP Chronic Seeking Care Surgeries In health LBP care, short- and long-term functional outcomes or quality of life indexes often best health care system’s resources capture these values. Table 1, on needed to deliver a service (e.g., page 28, illustrates this evoluHow can we reduce length of tion toward population-centric stay for hospital patients billed health care delivery. under a particular diagnosisrelated group [DRG]?). Population-centric programming looks at financial opportunity from a different perspective. We invert the funnel, and add other information that reflects the patient’s and community’s values (see Fig. 2). For example, knowing that conservative care often provides

A population-based program in action In its programming for the hip and knee replacement population, Fairview sought feedback from key community stakeholders and orthopedic experts. For this population, pain management is critical both for patient satisfaction and for progres-

Low Back Population Funnel:

300,000 100,000 57,000 People with Chronic LBP LBP

53,000 Work Limited

36,000 Seeking Care

4,000 Work Comp

sion of recovery. When pain is poorly managed, the health care delivered is of lower value, with lower community satisfaction and higher costs. Many surgeons and nurses from both the clinic and hospital perioperative teams commented that they can easily identify patients preoperatively who will not respond well to the standard pain management interventions following these procedures. Bringing together the

3,000 Completely Disabled

2,400 Hospitalized

600 Surgeries

clinic and hospital teams, we created a new service, Preoperative Pain Consults (POPCs), for patients at the University of Minnesota Medical Center. This service allowed surgeons to refer patients at high risk for poor postoperative pain management to Fairview Pain Management Center for a consult two weeks prior to surgery. The consult results in a pain management plan to be initiated in recovery and then maintained by an inpatient pain specialist during

Turning health programming inside out to page 28

Bringing Healthcare Home TM

P: 651.792.3860 TF: 877.309.4271 keymedicalsupply.com

| SUPPLIES | EQUIPMENT | HOME MODS | SERVICES |

Innovative programs. Outstanding customer service.™ ©2013 Key Medical Supply, Inc. Registered trademark of Key Medical Supply, Inc. All rights reserved.

November 2013 Minnesota Physician

17


Ophthalmology

K

eratoconus is one of the most common causes of full-thickness corneal transplants in the United States. Keratoconus is a noninflammatory ectatic disorder of the cornea characterized by a slowly progressive loss of corneal strength, with thinning and warpage of the cornea into a cone-like shape (see Fig. 1). This coning and thinning of the cornea causes high levels of irregular astigmatism to develop, often complicated by central corneal scarring. Historically, there has been no cure for keratoconus. Instead, treatment has focused on rehabilitation of vision, typically with specially fitted hard contact lenses. One of five patients with keratoconus would progress to such severity of disease that corneal transplantation was required to restore sight. Within the past decade, a new corneal treatment has revolutionized the care of keratoconus and other corneal ectatic

Keratoconus Corneal collagen-crosslinking advances treatment By Sumitra S. Khandelwal, MD, and Sherman W. Reeves, MD, MPH

disorders. Corneal crosslinking (CXL), developed by researchers at the University of Dresden, Germany, is the first therapy shown to halt the progression of this disease and even to im-

cornea. Ultraviolet light is then used to excite the riboflavin, releasing oxygen free radicals and causing increased covalent bonds to form between corneal collagen fibers.

Corneal crosslinking, developed by researchers at the University of Dresden, Germany, is the first therapy shown to halt the progression of this disease and even to improve vision. prove vision. In this treatment, riboflavin is applied topically on the eye and is absorbed by the

Results from multiple clinical trials across the U.S. and in other countries have shown that the resulting increase in corneal strength gained by crosslinking can halt the disease and possibly make corneal transplantation unnecessary. Corneal ectasia

Catered Living for urban seniors is arriving Nov 2014 with the Green Line at your door! Imagine living with the Fairview Avenue Green Line Station (your passport to the best of both cities plus the airport) at your door! Inside, The Terrace at Iris Park will offer Catered Living, a concierge approach to meeting your needs as they change. In addition, youâ&#x20AC;&#x2122;ll be part of our campus community - a 5-Star Urban Village for Seniors that offers a continuum of care. Learn more about what The Terrace at Iris Park and the six other residences on our campus have to offer, and how they all set the stage for Lifelong Living! Call Deb Veit for the whole story. 651-632-8800. Or visit EpiscopalHomes.org

18

Minnesota Physician November 2013

Corneal ectasia is a broad term encompassing several diseases that cause thinning and steepening of the cornea. The most common corneal ectatic disorders include keratoconus, pellucid marginal degeneration, and ectasia after LASIK. All of these disorders, which may represent a spectrum of the same disease, result in warpage of the corneal shape and induce irregular astigmatism. Irregular astigmatism results in high levels of visual blur and is not correctable with spectacles or soft contact lenses, which can only correct astigmatism that is regular and symmetric. Thus, these patients often require specially fitted hard contact lenses such as gas-permeable contact lenses and scleral contact lenses. Ectatic disorders of the cornea, such as keratoconus, are typically progressive conditions and bilateral in nature, though the two eyes may be affected

asymmetrically. Heredity plays some role in acquisition of the disease, though its development appears to be multifactorial and poorly understood. Multiple associations with other diseases exist, the most common of which is atopy. Atopic patients, who often suffer from concurrent allergic conjunctivitis, may precipitate or worsen underlying corneal ectatic tendencies by frequent eye rubbing. Two concerning issues in keratoconus are the progression of the disease and the patient population. The onset of the disease occurs in young patients, sometimes in the early teenage years. Patients are usually diagnosed only when their vision can no longer be fully corrected with glasses, prompting more complete ophthalmic evaluation and imaging of the corneal shape. The disease progression typically follows one of two courses: either a rapid progression to severe levels of visual impairment or a more indolent course, where functional vision is retained throughout life. Most progression occurs when patients are in their 20s and 30s, and tends to slow and stabilize when they are in their 40s and 50s as some agingrelated crosslinking of the corneal fibers occurs. In patients with severe ectasia or keratoconus-related corneal scarring, full-thickness corneal transplantation by penetrating keratoplasty (PK) may be required for visual rehabilitation. Though PK is potentially sight-saving, visual recovery from this procedure can take up to a year or more and often still requires the use of hard contact lenses for best vision. Furthermore, significant morbidity can occur from the surgery, including cataract, glaucoma, and rejection episodes of the transplanted tissue. Such an arduous postoperative process can cause significant hardship in the young patient population, limiting employment and recreation during this time frame. Additionally, the five-year survival rate of a corneal graft in the setting of keratoconus is 80 percent. Thus,


Figure 1. The photograph shows bulging of the cornea, consistent with keratoconus. Photo courtesy of David Hardten MD.

most young corneal transplant patients can expect multiple transplant surgeries in their lifetime. Finally, patients with transplanted eyes face a lifetime of possible complications such as infection due to immunosuppression related to chronic use of topical steroid drops; graft rejection; and potentially devastating graft dehiscence from even mild trauma to the eye. Corneal crosslinking Corneal crosslinking (CXL) was first reported in the 1990s at the University of Dresden. The initial efficacy and safety of crosslinking with riboflavin and UV light was demonstrated in rabbit and porcine eyes. Encouragingly, these models also showed that the therapy was not toxic to other parts of the eye, so long as the cornea was of a certain minimal initial thickness. Since the publication of the initial work, multiple human studies have echoed these results. Randomized controlled trials in keratoconus patients have shown stabilization and even improvement in the corneal shape in treated eyes compared to non-treated eyes, which continued to have ectatic progression. Long-term studies have also shown that improvement in the corneal shape may even continue for several years after the initial crosslinking treatment.

The introduction of crosslinking to the armamentarium of keratoconus treatment has also spurred investigation into combining crosslinking with other corneal therapies. One such therapy combines crosslinking with the placement of Intacs intracorneal ring segments. The Intacs device has shown efficacy in helping to reshape highly irregular corneas to which hard contact lenses can no longer be fitted. When combined with crosslinking, the Intacs procedure may result in even greater flattening of the central cornea in keratoconus, increasing corneal stability in comparison with the Intacs procedure alone. In addition, there is ongoing investigation into combining laservision correction therapy, such as topography-guided photorefractive keratectomy, with crosslinking in eyes manifesting early keratoconus. Though keratoconus has previously been an absolute contraindication to laser vision correction, the corneal stability gained by crosslinking may allow these eyes to be treated with advanced excimer laser ablations. The combination of these therapies may neutralize the irregular astigmatism of keratoconus, potentially restoring vision without the use of hard contact lenses.

Early detection

imaging gives additional information about regional corneal thickness abnormalities, and has been extremely useful in conjunction with topography for detecting early corneal ectatic change (see Fig. 2, on page 29). Both of these corneal imaging modalities are also used to follow keratoconic corneas after crosslinking treatment, and often show improvement in the topography weeks or months before the patient realizes any vision improvement.

The advent of corneal collagencrosslinking has made early diagnosis of keratoconus even more important, given that a therapy is now available to stop further ectatic progression. Corneal imaging technology has also advanced rapidly in the last decade, allowing earlier detection of corneal ectasia, though the initial change in a patient’s vision is still the usual precipitating event for further A new corneal treatment medical inhas revolutionized the vestigation care of keratoconus of corneal shape. Corneal topography is the primary method of assessing the stage and severity of keratoconus; it provides a topographic map of the cornea that shows areas of relative steepness or flatness compared to normal. Corneal tomographic

The ability of tomography and topography to help diagnose keratoconus at a very early stage may allow patients who have minimal keratoconus symptoms but are at high risk for progression, earlier access to crosslinking and, therefore, to avoid future ectasia-related comorbidities.

Keratoconus to page 29

The Lawyers and Lobbyists that Doctors Trust Medicine is complicated. So are the laws that doctors, hospitals and insurance companies have to manage. Lockridge Grindal Nauen is one of Minnesota’s leading health care law firms. Our health care clients are so satisfied they’ll write us a referral.

Contact Eric Tostrud

612-339-6900 ectostrud@locklaw.com

From the Courtroom to the Capitol.® November 2013 Minnesota Physician

19


Special focus: Rural health

F

Crossing the shaky bridge

ederal health care reform, passed in March 2010, has brought sweeping changes to the American health care industry. Medicaid expansion, health insurance exchanges, accountable care organizations, health information exchanges, and a host of other initiatives have either been introduced already or will be rolled out in the next few years. As a result of this marketbased transition from pay for volume to pay for value, health care providers must provide better care and better population health, at a lower cost to patients, third-party payers, and the broader U.S. economy. The formula, based on the Institute for Health Improvementâ&#x20AC;&#x2122;s Triple Aim, is: Better Quality + Improved Population Health = Value. This massive system change is putting intense pressure on rural hospitals and clinics to adapt to the new environment

The challenge for rural hospitals in a value-based future By Terry J. Hill, MPA, and Eric Shell, CPA, MBA

or risk becoming obsolete. To survive in the current (volume-based payment) system while preparing to do well in the future (value-based payment) system, rural hospitals

shaky bridge from the past era of health care to a future era fraught with uncertainty and challenges. Charging across the bridge too quickly might result in a tragic fall, possibly even

This system change is putting intense pressure on rural hospitals and clinics to adapt to the new environment or risk becoming obsolete. and critical access hospitals (CAHs) will need to cross the

I made the move to Minnesota Bank & Trust to offer my clients an exceptional banking experience. Call me for information on an opportunity to earn more interest while we earn your business.

Jennifer Resner VICE PRESIDENT, COMMERCIAL BANKING

952-841-9313

organizational death; neglecting to prepare to cross safely, taking steps that are too tentative, or staying in place until it is too late to move forward may prove equally disastrous. This article looks at the impact of health reform on rural health providers, as well as what providers can do now to prepare for the new health care reform models and value based reimbursementâ&#x20AC;&#x201D;and to take the first step across that shaky bridge. ACOs and rural providers

Get more interest from your bank and your banker.

20

Minnesota Physician November 2013

Among the most important factors driving health reform is the rapid expansion of accountable care organizations (ACOs) across the country. The emergence and growth of ACOs is a direct result of the deterioration of the fee-for-servicebased payment system. More than 300 ACOs may have been certified by Medicare by the end of 2013, with many similar models emerging from state Medicaid programs and private insurance providers. The political reform has already led to market reform momentum that will not be deterred by political elections or federal policy changes.

The ACOs developed to date have been fairly evenly divided between those that are hospital led, and those led by physician groups. The ACO requirement for at least 5,000 Medicare patients has resulted in most ACOs serving urban areas, but they have steadily expanded into rural areas. A new national rural hospital ACO is currently under development, but only a handful of certified rural ACOs have emerged to date. In June 2013, more than 4 million Medicare beneficiaries, or about 11 percent of the total Medicare fee-for-service beneficiaries, were receiving health care through ACOs, and the number was expected to increase rapidly. The ACO model is heavily based on primary care coordination, medical homes, and patient-centered care coordination, with chronic illness management, prevention, and wellness as other notable features. The expansion of ACOs will have significant implications for all providers. Value-based purchasing programs, for example, will shift payments from low-performing hospitals to high-performing hospitals. Acute care hospitals with higher than expected risk-adjusted readmission rates will receive reduced Medicare payments for every discharge. Physician payments will also be modified, based on performance against quality and cost indicators. The future value of rural hospitals lies partially in their relationships with local primary care physicians, and partially in the hospitals demonstrating high efficiency and quality. In this regard, they must achieve and publicly report high-quality outcomes and must closely monitor and actively pursue quality goals. They will also be challenged to coordinate care effectively and achieve high patient-satisfaction scores. Recent studies have demonstrated that critical access hospitals provide care to Medicare beneficiaries at a cost slightly lower than their urban coun-


terparts. CAHs also have the financial advantage of receiving cost-based reimbursement and may also have access to federal, state, and private grants. In contrast to the historic incentives to bring rural patients into large hospitals for treatment, we expect that large health systems and ACOs, in search of cost savings and value, will eventually try to drive low-acuity patients and other business to CAHs. This will be good news for rural provider. But in the short term, rural hospitals must meet numerous challenges that will severely test their resiliency. These include: • Recruiting and retaining the primary care physicians (PCPs) needed to serve the growing number of people with health insurance in rural communities. Though medical school enrollment has increased overall recently, the number of primary care residencies has not grown proportionately, and PCP salaries will increase with the increasing demand. • Participation in health information exchanges and patient databases will require health information technology that is often not available in rural areas. Rural hospitals and clinics trail their urban counterparts in electronic health record adoption, and ongoing costs of and access to needed technical expertise have become significant rural issues. • Rural hospital governance and leadership must become aware of the transformative changes taking place in the health care industry, and must begin to position their organizations to adapt to the changing marketplace. Achieving and documenting health care value won’t be accomplished overnight, and a journey of a thousand miles must begin with the first steps of expanding awareness.

• It seems clear that ACOs may be only an early model in the U.S. health industry’s evolution to more comprehensive, risk-based population health management. In other words, providers of the future will be financially incentivized to keep large groups of people healthy, manage

ment excellence • Expenses managed aggressively • Physician practices managed effectively • Effective organizational design • Increasingly lean financial, clinical, and opera-

Rural hospitals must achieve and publicly report high-quality outcomes and closely monitor and pursue quality goals. their chronic illnesses, and coordinate their medical care, increasingly in home-based settings. This will require greater collaboration with other types of community health providers and engaging the local community in self-care and disease prevention initiatives. Rural providers should begin now to learn about population health management and, in preparation for becoming community wellness centers, consider initiating wellness programs for their own employees.

tional processes The second initiative deals with primary care alignment. This is based on the assumption that revenue streams of the future will primarily be tied to primary care providers, which often comprise a majority of the rural hospital health-care delivery network. Thus, small and rural hospitals, through

alignment with their physicians, will have extraordinary value relative to costs. Therefore, it is important that rural hospital and rural physician leaders begin to discuss future partnerships and collaborative initiatives, and, when practical, work through formal agreements and shared leadership. The third recommended initiative calls for rationalizing the local health-services network. Rural health providers need to explore a wide range of affiliation options, ranging from network relationships, to interdependence models, to full asset ownership models. This also includes identifying the number of providers needed in a service area based on population, and then calculating the impact of integrated regional health-care systems. Under the ACA, rural hospitals are allowed to participate in more than one ACO, although rural physicians are

Crossing the shaky bridge to page 34

Launching initiatives to meet coming changes The evolution of the American health-care payment system will occur in phases, and rural providers should prepare accordingly, bearing in mind that form will follow function, which will follow finance. The four types of rural provider initiatives described below can be implemented in stages, designed to correspond with anticipated policy changes. The first initiative involves optimizing operating efficiencies, patient safety and quality. This is something any hospital or any medical clinic can focus on immediately. We define efficiency as:

Mayo clinic health SyStem – Springfield Springfield, Minnesota

Engan associatEs architects interior designers

shared vision innovative design

800-650-0860 www.engan.com

• Appropriate patient volumes meeting the service area needs • Revenue-cycle manageNovember 2013 Minnesota Physician

21


Special focus: Rural health

I

Southern Prairie Community Care

n 2010, the Minnesota Legislature authorized the Department of Human Services (DHS) to approve alternative payment/health care delivery projects for the Minnesota Medicaid population, using “alternative and innovative health care delivery systems organized by providers” (now known as the HCDS [Heath Care Delivery System] demonstration project). In 2013, DHS moved forward with its first set of HCDS pilot projects, focusing on the following primary goals:

HCDS pilot project for Minnesota Medicaid, through a contract with DHS, include:

• Encourage providers to innovate in order to deliver higher value care to Medicaid enrollees

• The provision of the full scope of primary care services and enhanced care coordination

• Support robust primary care and care coordination

• Engagement of patients and families in their care

• Test payment models that increase provider accountability

• Impact upon the quality and total cost of care (TCOC) through new models and strategies

• Create alignment with similar initiatives across payers The common elements of any

Improving costs and delivering higher value care in southwestern Minnesota By Keith Halleland, JD, and Mary Fischer, MSW

• Development of more meaningful community partnerships

Cutting edge expertise makes Episcopal Church Home your TCU of choice for patients requiring

Complex Wound Care

Introducing the newest member of our TCU team: Cristina Presbitero, BSN, RN, WCC

Cristina Presbitero is a Med-Surg and Wound Care Certified RN with over eight years of experience in complex wound care and enterostomal nursing and consulting. This means: • More wounds managed in house versus out patient, reducing total care cost and rehospitalization. • Wound vac management. • Track healing rates on hospital and house-acquired wounds, incident bases on diagnosis and risk factors, reducing hospitalization. Questions? Please contact our Admissions Coordinator Kelly Emerson at 651-632-8842

22

Minnesota Physician November 2013

• Gain sharing with providers, otherwise known as shared savings or pay-forperformance bonuses What this amounts to is a historic and unique opportunity for providers in Minnesota to work with DHS in serving the Medicaid population through new ACO-like structures (a provider-owned HCDS) and value-based reimbursement (gain sharing or pay-for-performance bonuses). The plan is that DHS and each pertinent HCDS would first establish a TCOC projected number on an annual basis for a certain population (e.g., $100 million for 10,000 people, aka “attributed lives”), and then attempt to reduce the TCOC number, and thereafter “split the savings” that had been created. Clearly, any of these new HCDS models would have to promote enhanced care coordination and disease prevention in order to succeed. Promotion of patient and family engagement, along with new, creative community relationships, embracing areas like mental health services, would be important. Exactly how that might work, however, is to be left to the ingenuity of each HCDS. Evolution of a new model of care delivery In 2006, a group of 12 counties in southwestern Minnesota, now known as Southern Prairie Community Care (SPCC), had begun discussing how they might help improve the delivery and cost of care to the Medicaid population in their counties. With the launch of the HCDS demonstration project though DHS, SPCC began to seriously explore designing a HCDS mod-

el in order to contract with the state under the HCDS demonstration project. Through a joint powers board formed in early 2012, SPCC decided to proceed with a formal HCDS planning process. They estimated that the HCDS would likely serve around 30,000 Medicaid enrollees in the counties involved: Chippewa, Cottonwood, Jackson, Kandiyohi, Lincoln, Lyon, Murray, Nobles, Redwood, Rock, Swift, and Yellow Medicine. SPCC sees itself as the first rural Accountable Community for Health in Minnesota and the nation. What that means to us is that SPCC exists for the purpose of improving the health of the counties’ Medicaid recipients, with the particular focus of reducing the impact of chronic diseases and mental health illnesses. This will be done through a public/private partnership, creating a new health system and day-to-day plan for how the public health and social service agencies can work more productively and efficiently with the medical sector on specific health improvement initiatives, as well as enhanced primary care, preventive health, and mental health services. We have embraced the notion that the quality of care delivered can be improved at the same time, and that patients and families will be more satisfied with the care and services they receive. We also believe these changes will eventually benefit all the people in our region, and not just the Medicaid population. Planning a cutting-edge project In 2013, SPCC responded to the second round of requests for proposals coming from DHS to establish an HCDS pilot site. In June 2014, SPCC was awarded the opportunity to contract for such a pilot, with a projected start date of Jan. 1, 2014. As this goes to publication, the contract between SPCC and DHS is still being finalized, and the work toward implementation of the pilot project is in full swing in the SPCC counties, involving each and every provider in the region.


During the two-year planning process, SPCC focused on the following key innovations for its HCDS pilot: Development of a care model that would include reliance on a “health care home” for each Medicaid enrollee, serving as the focal point for a new and improved level of care coordination for both physical and mental ailments. Inclusion of all medical and community providers in the service area with respect to both care delivery and shared savings/pay-for-performance bonuses, meaning that medical services and mental health services providers would all be engaged in care delivery and enhanced care coordination within SPCC. Chronic disease management and care coordination techniques that would result in higher quality care to the region, also leading to short- and long-term cost savings. While there are short-term savings that can be achieved through enhanced care coordination (e.g., fewer emergency room visits) the longer term goals include such things as reducing the level of diabetes in the region, a true population health objective. A health information exchange that would allow all the electronic medical record systems being employed by providers in the region to “roll up” into one shared medical data exchange, combining all pertinent medical and financial information needed to provide higher quality and more efficient care in “real time,” available at the fingertips of the providers in a user-friendly, focused, and consolidated manner. Without complete and adequate real-time medical data available at the provider level, enhanced care coordination and the reduction of chronic diseases is simply not possible, as a true picture of the “health” of the patient is piecemeal and inadequate rather than comprehensive and accurate. An enhanced focus on mental health problems and better care coordination for those

Improving the health of the counties’ Medicaid recipients, with the particular focus of reducing the impact of chronic diseases and mental health illnesses. suffering from a severe mental illness. Our preliminary data show that failure to adequately address and coordinate the needs of those suffering from a combination of mental and physical illnesses is one of the biggest areas of potential cost savings and quality improvement. Unfortunately, in today’s world, coordination of these services typically is insufficient to truly improve outcomes. A shared savings formula that was unique to the makeup of providers in the region and tied directly to “who can make a difference.” The idea here is that those providers with adequate influence over patient care should be rewarded for improving cost and quality outcomes, rather than simply for another procedure. The creation of a Southern Prairie Center for Community Health Improvement (SPCCHI), creating a public/ private partnership to establish health improvement goals for the region on an ongoing basis, with pertinent medical data readily available from the health information exchange, along with a governance structure that brings all key providers to the table for medical decisions required for the success of SPCC. In particular, this organization will be the place where the medical providers will meet to discuss health improvement strategies for the region, with access to necessary data and the support services of SPCC. Engagement of all public health and social service agencies in the region. SPCC believes that an important part of its success will lie in the redesign of public health and social services connected to the Medicaid population, to better coordinate the entire range of services provided, including housing, food, medical, transportation, and other services. This total-costof-services (TCOS) approach

support our efforts or intend to fight against us. First, this is a Minnesota effort, backed by both DHS and MDH. Minnesota has been a lead innovator in the Medicaid world for decades. The HCDS demonstration and the Accountable Communities for Health agenda being explored and fostered by both DHS and MDH are really part of a local and national trend of working directly with providers on a local level, in shaping the enhanced delivery of care and creating greater efficiency of costs. Innovations like those now available with electronic data and enhanced care coordination techniques are also key to seeing these new models become a success.

looks at better quality care and services coordination, aimed at reducing costs across the spectrum. Collaboration is key These key design elements of SPCC demonstrate the hard work and thoughtful planning in its development. All those involved are eager to see this new version of population health and the creation of a true Accountable Community for Health in southwestern Minnesota, a rural area where people believe that collaboration is the key to getting better results.

Keith Halleland, JD, is a founder of Halleland Habicht, a combined law and consulting firm in Minneapolis, where he focuses on regulatory compliance, business transactions, and health care policy. Mary Fischer, MSW, is executive director of Southern Prairie Community Care.

Along the way, many observers have asked how much of this SPCC effort is tied to the Affordable Care Act, and whether the health plans in Minnesota

driven by your

vision

At RJM Construction, we use insightful planning, a collaborative spirit and financial responsibility to help bring your vision to life.

GENERAL CONTRACTING CONSTRUCTION MANAGEMENT

952-837-8600 RJMConstruction.com

DESIGN/BUILD PRE-CONSTRUCTION

November 2013 Minnesota Physician

23


Special focus: Rural health

T

he 2012 statewide health assessment from the Minnesota Department of Health (MDH) has noted that “health starts long before illness is manifest; it begins in homes and schools, in jobs and workplaces, and in communities” (“The Health of Minnesota: Statewide Health Assessment,” MDH, April 2012). Now, as part of national legislation, an opportunity exists for the health care organizations, government agencies, and community members to join forces and strengthen the health care system at the local level. The Affordable Care Act (ACA) requires all nonprofit tax-exempt hospitals to conduct a Community Health Needs Assessment (CHNA) once every three years. The CHNA must include 1) a description of the community served by the hospital; 2) the process and methodology used in the assessment, the data sources, and other information used to identify

Community health needs assessment Planning and collaboration kickstart the journey By Colleen Spike, RN, and Mary Hildebrandt, PHN

community health needs; 3) input from those representing the broad interest of the community; 4) a prioritized process to identify community health needs; and 5) an implemen-

identified needs must be made widely available to the public on the hospital’s website, and a hard copy must be available on-site until the hospital’s two subsequent CHNAs are adopted

Health starts long before illness is manifest; it begins in homes and schools, in jobs and workplaces, and in communities. tation strategy to address the identified health needs. The results of the CHNA and ongoing strategy to address the

(potentially up to six years). Any public input on the CHNA must be documented and taken into consideration in the implementation of the existing CHNA or addressed in the subsequent CHNA. Rural CHNA and a planning pilot

Quality Transcription, Inc. Setting the standards for excellence

Quality Transcription (located in Minnesota) maintains a professional office environment, thus the confidentiality of your work is strictly maintained. We provide medical transcription services on a contract or overload basis. Our equipment is state of the art with 24 hour dictation lines and nationwide accessibility. We are experts in our field. We deliver on time. We have experienced staff. We monitor the quality of our work. We provide services tailored to your needs and will do whatever it takes to get the job done.

Quality Transcription, Inc. 8960 Springbrook Drive, Suite 110 Coon Rapids, MN 55433 Telephone 763-785-1115 Toll Free 800-785-1387 Fax 763-785-1179 e-mail info@qualitytranscription.com Website www.qualitytranscription.com

24

Minnesota Physician November 2013

In May 2012, Stratis Health, with support from the Minnesota Department of Health Office of Rural Health and Primary Care, invited two hospitals to join in an initiative to engage key community stakeholders across the continuum of care in a community-based process to improve health care in rural areas. (Stratis Health is Minnesota’s Medicare quality improvement organization, or QIO.) River’s Edge Hospital & Clinic, working in collaboration with Nicollet County Public Health, was chosen as one of the two hospitals and communities to participate in this unique project. In addition to identifying priority health needs in Nicollet County, the initiative was designed to build sustainable capacity for community engagement, assessment, and planning. The community and care providers are then better equipped to use their communi-

ty’s strengths, assets, and resources to meet their identified priority health needs. Identifying priorities The Nicollet County Community Health Assessment Team met for the first time in October 2012. The team’s objectives were to develop a vision of a healthy community; establish a common understanding of the current health of the community; and identify opportunities to make the vision a reality in Nicollet County. The team’s vision for a healthy community in Nicollet County included affordable and accessible health care; affordable but healthy food sources (fresh fruits and vegetables are often more expensive); access to exercise; programs and trails for the community; and public safety. In reviewing the community health profile for Nicollet County, the multidisciplinary health assessment team used several surveys, state and county data sources, and public health indicators to identify gaps in care and services within Nicollet County (see sidebar on page 25 for data sources). As the team analyzed the data, common themes and priority needs emerged, including awareness of and access to care; healthy teens and young adults; mental health; aging in place; transportation; healthy kids; and health and wellness. The team voted on these top priority areas and chose two to focus on within the CHNA and planning pilot: (1) mental health and (2) healthy teens and young adults. Gaps in care coordination topped the list for needed mental health services in Nicollet County. For the healthy teens and young adults theme, the identified top priorities for Nicollet County included bullying, binge drinking, hunger, and the availability of youth activities. To address the county’s needs in these areas, two multidisciplinary task forces were formed to: • Create a common vision among the members of the


Data Resources for Community Health Needs Assessment • Minnesota Student County Tables https://education.state.mn.us/MDE/StuSuc/SafeSch/MNStudentSurvey/ • County Health Rankings & Roadmaps www.countyhealthrankings.org • Nicollet County Data Book Southwest/South Central Health Survey www.wilderresearch.org • Atlas of Minnesota/US Census Bureau for Rural Policy & Development www.ruralmn.org/atlas-online/ • Minnesota Department of Health Center for Health Statistics www.health.mn.us/index.html

Healthy Teens & Young Adults and the Mental Health Task Forces • Seek broad representation on both task forces • Establish goals and objectives for the two task forces • Build capacity using local resources and assets • Identify existing gaps • Determine measurable baseline data and establish benchmarks • Develop a community-wide strategy to address the identified needs over the next three years • Implement the plan • Monitor the data and adjust the plan Mental health task force Provision of mental health services is a national crisis, with many facets and gaps in care coordination. At first, this priority need seemed almost too big to deal with on a local level. However, as the Nicollet County Mental Health Task Force continued to meet, it became apparent that there were gaps in care the task force could attempt to bridge. The task force met and identified the populations in need and those receiving mental health services within the county. The group acknowledged that a large number of people in the community who are living with mental health concerns are unable, unwilling, or unsure of where to seek services. Further, the discussions revealed that

even in the multidisciplinary task force (made up of social services, hospital professional staff, psychologists, law enforcement, educators, public health, and state-operated services), not all members were aware of the available resources. Therefore, one of the group’s first tasks was to identify the available resources to meet the needs of our patients and clients. The second area of concern centered on education. The Nicollet County Mental Health Task Force is exploring a program called Mental Health First Aid (MHFA). MHFA is an early intervention program that educates community members, first responders, doctors, nurses, clergy, and outreach workers on how to identify, understand, and respond to people showing signs of mental illness or substance abuse, and, ultimately, to connect them with appropriate care resources.

activities with little or no cost. It was particularly striking that the “tweens”—middle-schoolage adolescents—had few places to go that were safe and encourage healthy activity. The task force learned that two youth activities initiatives were under way in St. Peter. One is a multi-use recreational trail. Three individuals have established a plan for this trail and are currently meeting with leaders of the community for approval. The task force has met with them to find out how we can support their efforts. The other initiative is a skateboard path. This initiative has a plan, but will need funding and support from the community. Here, the task force will focus on gaining grassroots support from local groups and community members. A journey toward improved community health The CHNA is a journey that can

seem never-ending and full of surprises. However, the benchmark data collection done for the CHNA has provided measurable insight into where gaps in care and services exist—and has given us real hope of improving life for people in our community. Having input from a broad base of community stakeholders is invaluable in that it adds layers of understanding and focus on areas of concern. River’s Edge Hospital & Clinic and Nicollet County Public Health are just beginning this journey, but we are not in it alone. A good cross section of people from the community has joined forces with us in making Nicollet County a healthy and safe place to live. Colleen Spike, RN, is the CEO of River’s Edge Hospital & Clinic in St. Peter. Mary Hildebrandt, PHN, is the director of Nicollet County Public Health.

Healthcare Planning and Design

Healthy teens/young adults Supporting the health and well-being of teens and young adults was another area that seemed overwhelming for a small, local task force. At the initial meeting, the group looked at the areas of youth activities, bullying, binge drinking, and hunger. Ultimately, the task force decided to support youth activities initiatives that are already moving forward in the community. In its discussions, the group recognized that there are opportunities for youth to be involved with organized sports, but few places where they can participate in life-long exercise

Ad to come

Ophthalmology - Essentia Health

612.338.2029 | 218.727.8446

November 2013 Minnesota Physician

25


Special focus: Rural health

H

igh-tech imaging and subspecialty interpretation are no longer exclusive to metropolitan areas. Patients do not have to be transported via ambulance or helicopter to gain access to MRI and CT scans. Early intervention for trauma cases can be started immediately, right in the patient’s own local hospital. Advanced cancer staging exams with PET or MRI can be performed locally. Often, community-owned rural hospitals are making the investment in high-tech equipment. They are just as committed as their metro counterparts to practicing the high standards of patient care that comes with performing these exams at their facilities. But it’s not all about the machines. Having the equipment is only part of the equation. Providing optimal care is also about obtaining the most information possible from the imaging exam. This happens

Teleradiology Partnering with rural providers for long-term success By Nihar Shah, MD

when a subspecialty radiologist specifically trained and focused in that area interprets the study. Subspecialty interpretation of medical imaging is the standard of care in major metropolitan centers—and is becoming so in rural areas as well. Developing a partnership Mature teleradiology solutions are making subspecialty interpretation the norm in rural communities. Access to breast radiologists, neuroradiologists, or oncology-focused radiologists, for example, is now readily available in rural settings when

FAMILY PRACTICE w/OB Warroad, MN Roseau, MN Crookston, MN • Dedicated Team Approach • Competitive Salary & Benefits • EPIC Healthcare Information System Idylic Practice Opportunities located in family friendly communities with close access to some of Minnesota’s most beautiful lakes. Contact: Kerri Hjelmstad, Physician Recruiter Altru Health System PO Box 6003 Grand Forks, ND 58201-6003 1-800-437-5373 Fax: 701-780-6641 khjelmstad@altru.org

www.altru.org 26

Minnesota Physician November 2013

partnered with the right radiology group. In some instances, a local general radiologist works in conjunction with a subspecialty group. Moreover, working with a radiology group using teleradiology need not be an impersonal partnership. While there are some national radiology groups so large that it may be difficult to form relationships between local physicians and radiologists, there are other options. Most metropolitan mid- and large-sized radiology groups offer various levels of service to nearby rural communities. Partnering with a nearby group allows local physicians to work with a smaller pool of specialty radiologists that are available for phone consultations at any time. Better working relationships and communication can be developed, improving the care of patients and professional satisfaction of both referring physicians and radiologists. On-site coverage bolsters teleradiology Working with an in-state radiology group also allows for a combination of on-site care and teleradiology. Despite the advances in teleradiology, some exams/procedures require the on-site presence of a radiologist. For example, image-guided biopsies, abscess drainage, arthrograms, and pain injections require the physical presence of a radiologist. While there may be alternatives to some of these procedures, rural communities can better serve their patients and provide a broader range of services if their radiology partnership provides on-site coverage. Most radiology groups based in nearby cities typically provide

some form of scheduled on-site coverage for such procedures. For example, several subspecialty radiologists from Suburban Radiologic Consultants (SRC) travel weekly to hospitals and clinics in western Minnesota, giving patients in rural communities direct access to these physicians. This means that a woman who has a breast lump or a suspicious finding on her screening mammogram can undergo an evaluation and same-day biopsy performed by a breast radiologist, who gives the results directly to the patient. On-site coverage also helps justify acquisition of more advanced equipment at larger facilities in rural Minnesota, which can then serve as a more convenient referral site for smaller regional clinics and hospitals. Rice Memorial Hospital, in Willmar, recently installed a state-of-the-art interventional radiology suite. This investment serves patients not only in Willmar but also in many of the surrounding cities. SRC interventional radiologists use the new suite to provide focused cancer therapy such as tumor cryoablation or chemoembolization and vascular procedures such as dialysis fistula maintenance or angioplasty. Leveraging radiology resources Radiology groups can leverage resources at their own imaging facilities for their partners. Radiology groups often employ numerous technologists, information technology staff, medical records staff, nurses, and other health professionals with specific and valuable skill sets. These individuals can collaborate with staff at partner hospitals and clinics to improve imaging services. For example, lead technologists from SRC’s Twin Cities-based outpatient imaging facilities, Suburban Imaging, make site visits to partner rural clinics and hospitals. They may assist with training or deployment of new equipment. Alternatively, technologists from partner sites may spend time at a Suburban Imaging facility to learn a new exam


or to gain additional experience. Each site’s needs will vary based on local expertise, so a radiology group with broad experience and flexibility will be of value to rural partners. The benefits of collaborating with a larger regional group naturally expand to other supporting areas. For example, subspecialty radiology groups may provide their rural partners with assistance in meeting imaging accreditation requirements as well as navigating the accreditation process. As part of ever-changing oversight and billing requirements, both outpatient and hospital imaging facilities are seeking accreditation of their various imaging modalities. While this is becoming more and more necessary to receive payment for services, it is also important in building confidence with patients and health care providers. SRC’s outpatient imaging centers are all accredited by the American College of Radiology

and other accrediting agencies. SRC leverages the team involved in obtaining this accreditation to its rural partners, usually without cost. Most of our rural partners have already received accreditation in one or more modalities or are in the process of doing so.

communities. For example, a presentation by national breast imaging expert Louise Miller, RTRM, was hosted at The Breast Center of Suburban Imaging in Coon Rapids (a northern suburb of Minneapolis) and video-conferenced to mammography technologists in western Minnesota this past summer.

Benefits in cost, quality, care

Beyond imaging exam interpretation and leveraging resources, mid-size to large radiology groups can help their partners reduce their costs related to technology. Purchasing and maintaining radiology information management systems (RIS) and the software and hardware to store and retrieve images (PACS) is expensive and complex. Often it is more efficient to outsource this work to a radiology service provider. Costs are typically lower with this approach, as multiple smaller sites can leverage the same economies of scale available to large groups. Information technology costs to maintain these systems

The right radiology partnership can benefit in many other ways that are often overlooked. Rural facilities should be able to rely on their radiology group to provide assistance with quality control, continuous improvement projects, scanning protocols updates, radiation dose management, and more. When not on-site, subspecialty radiologists are able to participate in tumor conferences and offer case consultations via video and audio conferencing. Additionally, continuing education and enrichment programs can be broadcast from the metro area to physicians and staff in rural

24/7 also can be mitigated. Rural departments can stay focused on providing excellent patient care instead of managing software and hardware. Providing state-of-the-art patient care is at the core of partnerships between rural medical facilities and wellestablished mid-size to large regional radiology groups. These radiology practices provide direct access to subspecialty radiologists, leverage years of experience managing successful imaging facilities, and provide cost-effective technology solutions to achieve this goal. As high-tech imaging continues to advance, and the complexion of health care changes, an in-state radiology group makes an ideal partner for long-term success. Nihar Shah, MD, is medical director of the Greater Minnesota Partnerships for Suburban Radiologic Consultants, North Group. He subspecializes in body and breast imaging.

ONLY $99! (valued up to $224)

Opera for 2 This package includes: A pair of tickets A pair of Ordway drink or dessert vouchers One parking pass

for details, visit: mnopera.org/operafor2

612-333-6669 Mon. – Fri., 9am – 6pm

Così fan tutte, photo by Michal Daniel, 2011.

T i c keT Offi c e:

November 2013 Minnesota Physician

27


Table 1. Summary of the evolution toward population-centric health care delivery. Past

Present

Delivery focus

Provider-centric: FIX the patient

Patient-centric: CURE the patient

Accountable parties

Individuals/silo entities

Multidisciplinary teams

Individuals with the support of community entities in partnership with health care providers

Financial focus

Revenue

Reduce “cost” (direct costs to deliver care) to increase profit margins

Reduce cost (direct and indirect costs) to community

Quality metrics

Safety

Safety + process measures

Turning health programming inside out from page 17

the remaining hospital stay. In addition, the pain specialists provide direction on how the patients can safely taper off their opioids. In fewer than four months, the program grew to include additional orthopedic and neurologic populations; in less than a year, it was targeted to be available for all patients having elective inpatient surgeries on the campus. Although our initial focus was patient-centric— aiming foremost to improve the comfort of these patients—we quickly expanded to a more population-centric perspective. We understood that this work potentially could address the problem of opioid misuse and

abuse in larger populations. Knowing that about 70 percent of the surgeons educated at the University of Minnesota remain in the state to practice, we committed to providing our orthopedic residents additional training in perioperative opioid management. After a year, the hip and knee replacement population demonstrated a length of stay (LOS) of 1.35 days, less than the LOS for a clinically similar peer group that did not receive POPCs. The POPC patients were able to advance their inpatient physical therapy sooner compared to the other group, and they expressed great satisfaction with their pain management

Sioux Falls VA Health Care System Working with and for America’s Veterans is a privilege and we pride ourselves on the quality of care we provide. In return for your commitment to quality health care for our nation’s Veterans, the VA offers an incomparable benefits package. The VAHCS is currently recruiting for the following healthcare positions in the following location.

Sioux Falls VA HCS, SD Primary Care (Family Practice or Internal Medicine) Psychiatrist

Endocrinology Emergency Medicine Pulmonologist

Hospitalist Sioux Falls VA HCS (605) 333-6858 www.siouxfalls.va.gov Applicants can apply online at www.USAJOBS.gov

28

Future Population-centric: COLLABORATE with the patient and community to deliver better HEALTH to the patient

Safety + process measures + functional outcomes

and overall experience. The cost savings in delivering care to this population were significant; a system-wide integration would save $5.83 million and return nearly 2,500 more workdays to the community and 5,000 days to patients at home. Although all of the care entities already were delivering care well individually and as entity-based teams, the health system was able to achieve dramatic, sustained improvements at a lower cost through a population-centric approach to this type of surgery. Accelerating your care model evolution Change is challenging. Population-centric programming turns a lot of previously held truths for quality programming inside out. Throughout our journey in driving quality improvement, we have found the most success in using the following tactics: 1. Seek win-win opportunities. In the case of the POPCs, we began the service at a site where we had a highly interested physician and where the need for revamping site-wide pain management had recently been identified. 2. Always have a way to objectify program results. It is difficult to secure sustained resources without supportive data that extend beyond anecdotes. 3. Use the data. Even if the data do not conclusively determine a direction, they can drive a discussion, tell a story, and help you better understand your population. Use stories to build and maintain momentum, especially for those delivering the care. 4. Do not AIM for what is BEST; DO what is BETTER. Population-

Minnesota Physician November 2013

centric programming involves a large number of stakeholders, and rarely will everyone agree on a “best” course of action. However, people often can agree on what will yield a better result than the current state. Incremental progress is still progress. 5. Work from values held in common. Overwhelmingly, care providers care foremost about the people they serve. When working across many entities, focus on improving the quality of care and the patient experience rather than focusing on any financial goal. 6. Bring your grit. The value of imagination and persistence cannot be underestimated in populationcentric programming. Providing better health at a lower total cost to the community requires health systems to move out of their provider silos and roles, and even beyond multidisciplinary teams, and look at ways to partner with various community entities. A strong, system-level commitment to population health will help erode the most challenging barriers to population-centric programming: silo thinking, misaligned incentives, competing priorities, and fear of change. By moving beyond traditional health care delivery, we can bring higher value health to our communities and the populations we serve. Emily Karlen, MPT, is senior project management consultant for orthopedics at Fairview Health Services and has been recognized regionally for innovations in health care delivery.


Figure 2. Pentacam topography of a patient with keratoconus. In this imaging, warmer colors indicate steepening, with most patients having a range of blue and green. The bottom left picture shows an area of steepening, which is notably more yellow and orange than the rest of the topography.

Keratoconus from page 19

FDA approval of CXL

A promising treatment

CXL has now been performed in Europe and elsewhere in the world for more than a decade, but it is still not FDA-approved in the U.S. However, several ongoing clinical trials in the U.S. allow patients access to crosslinking treatment. Our ophthalmology group has done clinical trial work in several previous crosslinking studies and is currently part of the CXLUSA study group (www.cxlusa.com). This surgeon investigator study group is allowed to treat keratoconus, post-LASIK ectasia, and similar ectatic corneal problems, and to perform treatments combining crosslinking therapy with other corneal surgeries.

Keratoconus is a rare but potentially devastating ectactic disease of the cornea, frequently resulting in vision loss from irregular astigmatism and corneal scarring. While traditional therapy for keratoconus and other similar ectatic disorders has been limited to hard contact lenses and corneal transplantation, corneal collagen-crosslinking now offers an avenue to slow or halt the progression of the disease and to limit the development of further keratoconus complications. Sumitra S. Khandelwal, MD, and Sherman W. Reeves, MD, MPH, practice ophthalmology at Minnesota Eye Consultants.

Meet your unique financing needs with our Doctor Loan If you are a medical resident or licensed, practicing doctor, dentist or other eligible medical professional, the Bank of America Home Loans® Doctor Loan could help you make the move to your next home.¹ It offers many home financing advantages, including:² • As little as 5% down on mortgages up to $850,000 • Employment start date up to 60 days after closing allowed • Student loan debt not included in total debt calculation • A range of fixed- and adjustable-rate loans I’m here to help you with your Doctor Loan. From start to finish, you can count on me for excellent service and expert guidance. Contact me to learn more. Dan Mills Mortgage Loan Officer NMLS ID: 421409 651.334.9589 Cell dmills@bankofamerica.com mortgage.bankofamerica.com/dmills

¹An applicant must have, or open prior to loan closing, a banking relationship with Bank of America, which can be, at a minimum, a checking or savings account. ²Restrictions apply. Ask for details. Credit and collateral are subject to approval. Terms and conditions apply. This is not a commitment to lend. Programs, rates, terms and conditions are subject to change without notice. Bank of America, N.A., Member FDIC.l Equal Housing Lender. ©2013 Bank of America Corporation. 00-62-2358D 08-2013 ARN9HAN3

November 2013 Minnesota Physician

29


Physical medicine/Rehabilitation

P

atients frequently report cognitive problems during cancer treatment, especially with chemotherapy. Typical complaints are forgetfulness, word-finding difficulty, trouble concentrating, difficulty multitasking, mental fatigue and inefficiency with previously easy tasks, inability to follow the flow of a conversation, and getting lost in previously familiar locations. It is not entirely clear why some patients have cognitive changes with cancer treatment and others don’t. Cognitive difficulties during and after cancer treatment can also be related to anxiety, pain, insomnia, electrolyte imbalances, medications, cancer or paraneoplastic effects of the central nervous system, and hormonal changes. But these factors alone do not account for the familiar pattern of cognitive changes reported by cancer patients who have no underlying medical reason for cognitive change.

Cognition and cancer Finding focus after chemotherapy By Nancy Hutchison, MD, and Mary V. Radomski, PhD, OTR/L A growing body of research has led to the conclusion that “chemobrain” is real. Chemobrain is now called mild cognitive impairment (MCI) of cancer treatment, reflecting the multifactorial nature of the problem. However, there is strong evidence that the pattern of decline in verbal and visual spatial ability is primarily attributable to chemotherapy and remains as a measurable impairment over time. A recent meta-analysis of the problem showed that the deficits remain for over six months after completion of chemotherapy

Fairview Health Services Opportunities to fit your life Fairview Health Services seeks physicians to improve the health of the communities we serve. We have a variety of opportunities that allow you to focus on innovative and quality care. Be part of our nationally recognized, patient‑centered, evidence‑based care team. We currently have opportunities in the following areas: • Dermatology • Emergency

Medicine

• Geriatric

• Pediatrics

Medicine

• Psychiatry

• Hospitalist

• Endocrinology

• Internal Medicine

• Family Medicine

• Med/Peds

• General Surgery

• Ob/Gyn

• Rheumatology • Sports Medicine • Urgent Care • Vascular Surgery

Visit fairview.org/physicians to explore our current opportunities, then apply online, call 800‑842‑6469 or e-mail recruit1@fairview.org

(Jim, H et al., 2012, J Clin Oncol 30:1–12). Alterations of cerebral white matter on MRI have been detected in patients with cognitive changes after chemotherapy compared to healthy agematched controls. (Depres, S et al., 2011, J Clin Oncol 29:1–8). The National Comprehensive Cancer Network (NCCN) has recently published clinical practice guidelines for Cancer Survivorship (v 1.2013. nccn. org). Cognitive function is one of the eight major areas for screening and treatment for cancer survivors. A review of the science be-

hind cancer-related MCI concluded that about 25 percent of cancer survivors have MCI and that interventions for treating the condition are beneficial (Ahles TA et al., 2012, J Clin Oncol 30:3675–3686). Chicken or egg? One difficulty confronting the clinician in treating the cancer survivor reporting distress and/ or cognitive difficulty is the chicken-or-egg phenomenon. The awareness of acute cognitive decline is anxiety producing, leading to distractibility and more cognitive difficulty. Lack of familiarity with MCI by medical providers, family, and friends may contribute to feelings of isolation, fear, loss of control, and hopelessness. A recent study showed that patients who developed cognitive problems related to cancer treatment had higher distress scores (Ploos van Amstel, FK, 2013, Support Care Cancer 21:2107–2115). When cognitive treatment does not alleviate distress, or when

Emergency Medicine

Emergency Practice Associates has immediate full-time, part-time and locums opportunities at our sites in:

Hibbing Little Falls Park Rapids Alexandria Austin

For more information contact Tina Dalton or Mike Coulter at 800-458-5003, email:

recruiting@epamidwest.com or visit our website at

www.epamidwest.com

Sorry, no J1 opportunities.

fairview.org/physicians TTY 612-672-7300 EEO/AA Employer

30

Minnesota Physician November 2013

Your Emergency Practice Partner


Problem in daily life Absentmindedness: Forgetting

where she parked her car; forgetting what she intended to do from moment to moment; making errors during meal preparation

Central cognitive issue Poor encoding: Mrs. R. often had so much on her mind that she did not focus her attention long enough to encode new information.

Cognitive strategies that Mrs. R. learned and implemented Pausing: Mrs. R. learned to recognize when her thoughts were racing and to stop and to take mental inventory of what she was doing, feeling, thinking. Avoiding multitasking: Mrs. R. found that she could greatly reduce errors during meal preparation if she focused on the task at hand rather than trying to do two or three other chores at the same time.

Jotting notes: Mrs. R. realized that she was most prone to absentmindedness when fatigued. On such occasions, she simply jotted notes on a small notepad regarding parking locations or “to do” items that came to mind. Disorganization: Being unable

to begin an unstructured activity; easily overwhelmed and quickly quitting activity

Fatigue: Mrs. R. typically started to sort her photographs after dinner; fatigue interfered with her concentration and problem-solving.

there is significant evidence for clinical depression, a referral to a mental health professional is indicated in addition to cognitive remediation therapies. Rehabilitation After ruling out medical and neurologic causes of cognitive decline, the clinician should refer the patient to a rehabilitation professional (usually an occupational or speech therapist) to provide the patient with cognitive therapy. Medications have little benefit for patients with

Pacing: Mrs. R. found that she could successfully complete repetitive household tasks (like folding laundry) during her low-energy times of the day and started reserving complex tasks (like her photography project) for peak energy times of her day or week. Means-ends analysis: Mrs. R. found that she could not only complete but also enjoy her photography

project if she separated planning from doing. She broke the project into smaller steps and kept a written list of those steps, tackling them one at a time.

MCI unless there are coexisting medical or psychiatric conditions. Modafinil has been studied and has shown some limited promise. However, most patients do not want or need medication; and medication cannot address the social, psychological, and practical aspects of daily living with MCI that are part of the rehabilitation professional’s treatment. Financial and side effect concerns are additional negative factors with medications. These rehabilitation approaches appear to minimize

problems associated with chemobrain: • Learning new cognitive strategies. Patients work with a cognitive therapist to implement “workarounds” (e.g., using note-taking strategies, planning techniques, timers, and smart technology) that help improve their performance on daily activities. • Engaging in physical exercise. Even light exercise or physical activity that

uses skeletal muscles and expends energy has benefit for cognition in cancer survivors (Fitzpatrick, T et al., 2012, J Psychosoc Oncol 30:5, 556–572). • Performing brain-training exercises. Patients perform commercially available computer-based exercises (such as Lumosity and PositScience) that challenge speed of processing, memory, and concentraCognition and cancer to page 32

Minneapolis VA Health Care System Great place to work, great place to live.

You are invited to be part of the Department of Veterans Affairs that has been leading change in the health care sector. The Minneapolis VA is a 341-bed tertiary care medical center affiliated with the University of Minnesota. Our patient population and case mix is challenging and exciting, providing care to veterans and active-duty personnel. The Twin Cities area offers excellent living and cultural opportunities. Opportunities for full-time and part-time staff Physicians are available in the following positions: • Gastroenterologist • Emergency Department • Hematology/Oncology • Internist, w/Women’s Health Experience • Compensation and Pension • General Internal Medicine (Minneapolis) • General Internal Medicine (Rice Lake/Hayward, WI Outpatient Clinic) • General Internal Medicine (Chippewa Falls, WI Outpatient Clinic) Physician applicants should be BC/BE. Possible recruitment bonus. Interested applicants should email CV to Joan L. Potter, HRMS, Joan.potter@va.gov

Fax 612-725-2287 Telephone 612-629-7306 EEO Employer.

November 2013 Minnesota Physician

31


Cognition and cancer from page 31

tion. While the impact of brain training on daily life activities remains unclear, these activities are safe and often enjoyable and show promise in terms of before-and-after effects on cognitive testing. Chemobrain case study The following case example illustrates how all of the above approaches are used to address chemobrain. After ruling out brain metastases, Mrs. R.’s physician referred her to occupational therapy when she described persistent problems with forgetfulness and distractibility that began during her chemotherapy for breast cancer. For example, in the past month, Mrs. R. lost her car in the mall parking lot; made errors when preparing easy, familiar meals for her family; couldn’t figure out how to organize photographs for her daughter’s graduation party;

and was increasingly withdrawn at work for fear of being unable to remember words, names, or express herself. Furthermore, it was evident that Mrs. R. suffered from poor sleep, fatigue, and disrupted daily routines. Mrs. R. was most anxious to “fix” the problem so that she could minimize the burden on her husband and daughters and, ultimately, gain enough confidence and stamina to return to work full time. The occupational therapist recommended four weekly outpatient visits at which they would explore new strategies for more effectively accomplishing activities that mattered most to Mrs. R. Each session focused on 1) understanding the central cognitive issue that disrupted performance; 2) training in new cognitive strategies or approaches; and 3) problem solving regarding implementation of these strategies specific to Mrs. R.’s daily activities. The occupational therapist hypothesized that alternate approaches would

decrease Mrs. R.’s experience of failure and distress, and improve her everyday performance and sense of competence. The table on page 31 provides examples of strategies that proved effective in addressing some of Mrs. R.’s primary concerns. The examples link daily life problems, cognitive issues, and strategies. Concurrent with her outpatient occupational therapy, Mrs. R. implemented a physical and cognitive fitness regimen. She started and adhered to a daily walking schedule and spent time each day on the computer playing games that challenged her memory and concentration. At the time she discontinued occupational therapy one month later, Mrs. R. described substantial improvements in her cognitive functioning. Mrs. R.’s improvements at home seemed to buoy her confidence at work. She reported that many of the strategies that had proved helpful at home were also helping her at work. While she still did

not see herself as “100 percent,” Mrs. R. was less anxious about her performance and reported that she felt better able to cope with her remaining, intermittent cognitive concerns. Chemobrain is real Cognitive impairment in cancer survivors is a real phenomenon that has a negative impact in the domains of vocational, social, and emotional health. Rehabilitation strategies provided by cognitive therapists (occupational therapists and speech language pathologists) are beneficial in improving function and quality of life. Therapy is usually only a few sessions, but provides significant benefits for cancer survivors with this condition. Nancy Hutchison, MD, a boardcertified physiatrist, is medical director for cancer rehabilitation and survivorship at Courage Kenny RehabiIitation Institute and the Virginia Piper Cancer Institute in Minneapolis. Mary V. Radomski, PhD, OTR/L, is a clinical scientist at Courage Kenny Research Center.

Trinity Health

One of the region’s premier healthcare providers.

Currently Seeking BC/BE • Ambulatory Internal Medicine • General Surgery • Psychiatry

• Urology • Neurology • Otolaryngology

Contact us for a complete list of openings.

Based in Minot, the trade center for Northern and Western North Dakota, Trinity Health offers the opportunity to work within a dramatically growing community that offers more than just a high quality of life. Comprised of a network of nearly 200 physicians in hospitals, clinics and nursing homes, Trinity Health hosts a Level II Trauma Center, Critical Care Helicopter Ambulance, Rehab Center, Open Heart and Lung Program, Joint Replacement Center and Cancer Care Center. Physicians are offered a generous guaranteed base salary. Benefits also include a health and dental plan, life and disability insurance, 401(k), paid vacation, continuing medical education allowance and relocation assistance.

www.trinityhealth.org

32

Minnesota Physician November 2013

For immediate confidential consideration, or to learn more, please contact

Shar Grigsby Health Center - East 20 Burdick Expressway Minot ND 58702 Ph: (800) 598-1205, Ext 7860 Pager #0318 Email: shar.grigsby@trinityhealth.org


Emergency Room Physicians Looking for leisure work hours? • Set your own hours • No contract • No obligations

Attention Physicians • Immediate openings • Casual weekend or evening shift coverage

• Choose from 12 or 24 hour shifts • Competitive rates • Paid malpractice

Great Emergency Department in Southern Minnesota

763-682-5906 • 1-800-876-7171 F-763-684-0243 michelle@whitesellmedstaff.com

Minneapolis VA Health Care System Physician/Physiatrist

The MVAHCS, affiliated with the University of Minnesota, is seeking a Spinal Cord Injury and Disorders BE/BC physician/physiatrist. Duties include providing interdisciplinary care for acute and chronic SCI/D Veterans in the inpatient and outpatient setting. Staff has on-site access to medical and surgical specialties, advanced imaging techniques, and state of the art electronic medical record. Opportunities exist for interacting with medical students, residents, and other health professions trainees. SCI/D Fellows strongly encouraged to apply. Be a part of this dynamic and rapidly growing SCI/D Center in a great location. Must have a valid medical license anywhere in the US. Must be US citizen. VA physicians enjoy an excellent benefits package, paid malpractice insurance, and competitive salary and benefits. Recruitment incentive and student loan repayment may be authorized.

For more information: Visit www.usajobs.gov or email your CV to Robyn.Owings@va.gov Telephone 612-467-4337 EEO employer

Orthopaedic Surgery Opportunity Live in Beautiful Minnesota Resort Community

Two BC/BE Orthopaedic Surgeons wanted to join four orthopaedic surgeons at Sanford Bemidji Orthopaedics Clinic in Bemidji, Minnesota. Part of an 85-physician, multi-specialty group practice and 118 bed acute care hospital. 1:6 call anticipated. Competitive compensation/benefits package, paid malpractice, relocation assistance and more. Sanford Health of Northern Minnesota has 1,450+employees and is part of Sanford Health system based in Fargo, ND and Sioux Falls, SD. Bemidji, Minnesota, located in northwestern Minnesota, is a beautiful resort community offering exceptional schools, a state university, and yearround cultural activity as well as great access to the outdoors for year-round recreation activity. To learn more about this excellent practice opportunity contact: Kathie Lee, Director Physician Placement Phone: 701-280-4887 Fax: 701-280-4136 Email: Kathie.Lee@sanfordhealth.org AA/EOE

November 2013 Minnesota Physician

33


Crossing the shaky bridge from page 21

limited to only one ACO. The fourth recommended initiative is to develop population-based payment strategies to correspond to the anticipated payment and implementation phases. These would be: • Developing self-insurance strategies for integrated delivery systems and self-insured employers • Developing commercial payer strategies • Developing Medicare strategies • Developing Medicaid strategies These strategies will undoubtedly require access to advanced business and financial expertise that is fully aware of anticipated reimbursement policies and changes. Of special note is the growth of community care organizations (CCOs),

which establish a new “market” for insurers and providers to come together to manage health care expenditures for a defined population. In the new models, hospital beds, once considered revenue generators, will rapidly become cost

vantageous. The ultimate goal will soon become managing the health of large populations, at lower costs, with higher quality outcomes. Charting a new course Rural hospitals and rural

Health education, care coordination, telehealth, and other services will be, for the first time, generators of revenue for both hospitals and physicians. centers. Health education, care coordination, telehealth, and a variety of other prevention and chronic illness services will be, for the first time, generators of revenue for both hospitals and physicians. For example, keeping a patient in his or her rural home with telemedicine coverage, rather than in a hospital bed, will prove financially ad-

physicians have historically dealt with the acute challenges related to serving an older, sicker, poorer, and geographically isolated population. With fewer providers per capita, with limited technology and expertise, and with the cards usually stacked against them, these providers have often served heroically in rural communities

across the country. The current environment, driven by health care reform and market realities, now offers a new set of challenges. Many rural health care providers have not yet considered either the magnitude of the changes or the required strategies to appropriately address the transformational change. Crossing the shaky bridge from one era to the next will not be easy, but rural providers have much to offer in terms of value. They should begin now to increase their awareness, calculate their assets, and begin to chart a course into the future. Terry J. Hill, MPA, is executive director of the National Rural Health Resource Center, based in Duluth. Eric Shell, CPA, MBA, is a principal at health consulting firm Stroudwater Associates.

Urgent Care We have part-time and on-call positions available at a variety of Twin Cities’ metro area HealthPartners Clinics. We are seeking BC/BE fullrange family medicine and internal medicine pediatric (Med-Peds) physicians. We offer a competitive salary and paid malpractice. For consideration, apply online at healthpartners.jobs and follow the Search Physician Careers link to view our Urgent Care opportunities. For more information, please contact diane.m.collins@healthpartners.com or call Diane at: 952-883-5453; toll-free: 1-800-472-4695 x3. EOE

© Paid for by the U.S. Air Force. All rights reserved.

AIRFORCE.COM/HEALTHCARE

healthpar tners .com © 2013 NAS (Media: delete copyright notice)

34

Minnesota Physician November 2013

MN Physician 4" x 5.25" 4-color


The perfect match of career and lifestyle. Affiliated Community Medical Centers is a physician owned multispecialty group with 11 affiliate sites located in western and southwestern Minnesota. ACMC is the perfect match for healthcare providers who are looking for an exceptional practice opportunity and a high quality of life. Current opportunities available for BE/BC physicians in the following specialties: • ENT • Family Medicine • Geriatrician/Outpatient Internal Medicine • Hospitalist • Infectious Disease

• Internal Medicine • Med/Peds Hospitalist • OB/GYN • Oncology • Orthopedic Surgery • Psychiatry

• Psychology • Pediatrics • Pulmonary/ Critical Care • Radiation Oncology • Rheumatology

For additional information, please contact:

Kari Bredberg, Physician Recruitment karib@acmc.com, (320) 231-6366

Julayne Mayer, Physician Recruitment mayerj@acmc.com, (320) 231-5052

Opportunities for full-time and part-time staff are available in the following positions:

• Associate Director, Primary & Specialty Medicine (IM)

• Medical DirectorExtended Care & Rehab (Gariatrics)

• Dermatologist

• Pain Specialist

• Geriatrician/ Hospice/ Palliative Care

• Psychiatrist

• Internal Medicine/ Family Practice

• Urgent Care Physician (IM/ FP/ ER)

Applicants must be BE/BC.

www.acmc.com

Opportunities available in the following specialties: Dermatology Southeast Clinic

Olmsted Medical Center, a 150-clincian multi-specialty clinic with 10 outlying branch clinics and a 61 bed hospital, continues to experience significant growth. Olmsted Medical Center provides an excellent opportunity to practice quality medicine in a family oriented atmosphere. The Rochester community provides numerous cultural, educational, and recreational opportunities. Olmsted Medical Center offers a competitive salary and comprehensive benefit package.

Family Medicine Pine Island Clinic Southeast Clinic

Internal Medicine Southeast Clinic

Women’s Health Pavilion (Hospital)

Hospitalist

Rochester Hospital

Plastic Surgeon Hospital

Send CV to: Olmsted Medical Center Administration/Clinician Recruitment 102 Elton Hills Drive NW Rochester, MN 55901 email: dcardille@olmmed.org Phone: 507.529.6748

US Citzenship requited or candidates must have proper authorization to work in the US. Physician applicants should be BE/BE. Applicant(s) selected for a postion may be eligible for an award up to the maximum limitation under the provision of the Education Debt Reducion Program. Possible recruitment bonus. EEO Employer.

Commpetitive salary and benefits with recruitment/ relocation incentive and performance pay possible. For more information: Visit www.USAJobs.gov or contact Nola Mattson, STC.HR@VA.GOV Human Resources 4801 Veterans Drive, St. Cloud, MN 56303

(320) 255-6301

Fax: 507.529.6622

NOVEMBER 2013 MINNESOTA PHYSICIAN

35


Screening for risky substance use from page 12

over time. Getting honest answers. “Many patients think heavy drinking and even some drug use is normal,” said Bixby. “So some view screening for alcohol or drug use as invasive and inappropriate.” “Patients are not always truthful,” added Somers. “They try to minimize their actual substance use. It is viewed as a social activity, not a health problem like depression.”

“When we create a comfortable environment, we are more likely to get accurate answers,” said Rebecca Godfrey, care coordinator, North Memorial. “It is not what we say, but how we say it.” Folding the alcohol and other drug screenings into overall patient health assessments also helps to destigmatize the discussion of risky substance use for North Memorial. In smaller communities, clinic staff and patients may know each other, making it uncomfortable for both parties to discuss the issue. However, a number of clinics noted that patients are more open than they originally thought to talk about their substance use. Others are relieved that someone is finally talking about the issue because they didn’t know how to bring it up.

Training in motivational interviewing helps care managers better align with patients as collaborators. This helps remove judgment and strengthens patient self-efficacy. Nancy Munson, RN, Integrated Behavioral Health Care, Mayo Clinic, said, Accessing outside “Making patients aware of the medical complications resulting resources. “Knowing what external resources are available from binge drinking makes it easier for them to buy into some for patients with substance use issues is very important for behavioral change.” 9847-1001_MLHS_MN_Med7_8_13_Layout 1 7/8/13 11:14 AM Page 1

those requiring more than a brief intervention,” said Greta Humphrey, care coordinator, North Memorial. Entira developed a list of resources and invited leaders of various organizations to share information on their programs. Gaining buy-in from psychiatrists. “Psychiatrists may initially worry about losing work or possible liability issues if they consult with a care manager in primary care instead of performing direct patient care,” said Sawyer. “The reality is that there haven’t been problems. The results speak for themselves.” Support for a care management approach Clinics indicated that the factors making depression care successful in primary care also apply to risky substance use treatment. These include: • Obtaining senior management commitment • Finding a strong clinic champion • Having a registry to monitor patient progress • Sharing early success stories to validate the model

Live in the relaxed lake country of Mille Lacs and practice medicine where you will make a difference. We’re looking for a Family Physician to join us at Mille Lacs Health System in Onamia, Minnesota. Loan forgiveness options – J-1Visas considered. Contact: Fern Gershone: fgershone@mlhealth.org or Dr. Tom Bracken: tbracken@mlhealth.org

Caring for body, mind and spirit. Onamia, MN • mlhealth.org • 877 - 535-3154 7 FAMILY PHYSICIANS • 9 PAs • CRITICAL ACCESS HOSPITAL ER STAFFED 24/7 • ATTACHED GERIATRIC UNIT & LTC FACILITY • 4 CLINICS

36

Minnesota Physician November 2013

• Helping staff feel good about the care they provide • Hiring care managers who work well in a team, have compassion for patients with behavioral health conditions, and are skilled in motivational interviewing Outcomes and measurement To date, Minnesota clinics have screened roughly 26,000 patients for risky substance use. Three percent were eligible for a brief intervention and, of those, 40 percent completed the intervention. At follow-up, 80 percent of these patients reported a decrease in binge drinking days (men consuming five or more drinks and women consuming four or more drinks in about two hours). Clinics are seeing successes. Tianna Harrell, care coordinator, North Memorial Health

Care, helped a patient with possible alcohol abuse access a treatment program for teens, and the young woman graduated from the program. “She invited me to the ceremony and said she doesn’t know what she would have done if she hadn’t gotten into the program,” said Harrell. At Entira, Angela Rivas, care manager, remembers a patient who acknowledged using heroin. “He had been using for two years and had hooked his girlfriend,” said Rivas. “He hadn’t told his parents or his doctor. In fact, his doctor was shocked when he found out. We sent this patient to treatment, and he’s doing phenomenally well.” “Down the road, I hope we have more outcome data,” said Tim Hernandez, MD, Entira. “Referral to treatment makes it difficult to know patient outcomes because of confidentiality. Long-term studies have to be done to determine the benefits of keeping patients from moving from abuse to addiction. If we can start to see that this works upstream, that would be huge.” The bottom line While outcomes are still being gathered about how the evidence-based SBIRT model was implemented, current participants support the program. “The staff has embraced this work, and we are seeing progress,” said Bixby. Hernandez noted that the further integration of behavioral health into primary care “is coming whether we want it or not. Clinics should figure out their process.” “Screening for risky substance use has been incredibly valuable,” said Virant. “When we’re dealing with behavioral health issues, alcohol and drug use can often be major comorbidities. In retrospect, not to have acknowledged that would have been foolish. We have the first new tool in a long time that’s proven to work.” Pam Pietruszewski, MA, ICSI director, leads the SBIRT initiative at ICSI.


One team, one bill from page 10

surgery could cost roughly $40,000, while that same procedure with a stay in the Excel recovery retreat almost cuts the cost in half to $21,000.

far as the billing goes, not hearing from six or seven different entities.”

Since the nation’s computerized health care billing system is built around a fee-for-service model, insurers are working We have found that the to accommodate TCO’s $21,000 “sticker price” is about bundled-payment approach. 30 percent less than what inCurrently, HealthPartners and surance companies in the Twin Medica are participating insurCities pay for a typical knee reers. Going forward, TCO plans placement. By using on-site staff to continue negotiating with and resources, TCO has taken other insurers and payers. much of the guesswork out of This financial model of bunthe costs of the procedure and dled payment could be applied recovery time. The Excel team to any procedure that is elecprovides all the before and after tive and has a clear start and care, handles the lab work and end point. As a specialty, knee the medications, and performs surgery is ideal for bundled the surgery at their outpatient payment, but this model is also surgery center. The cost savings applicable to other specialties, is substantial no matter who is such as gastroenterology (e.g., footing the bill, patient or insurfor colonoscopy). ance provider. Of the all-inclusive price, Simonson says, “Patients love it. There are no surprises, we give full disclosure on the price, and they’re only dealing with us as

Taking on risk TCO is a physician-owned practice and takes on the majority of the risk of covering the knee

replacement procedure. The Excel program stresses a pre-operative comprehensive educational session with the patient and caregiver. In addition, best practice protocols for the program have been developed and established by the physicians and their care team to ensure that the highest quality of care is delivered throughout the care continuum. These factors contribute to patients and caregivers feeling confident and prepared, which in turn has resulted in improved recovery and extremely high patient satisfaction. Opportunities for growth Hip and knee replacement patients are trending for younger people. Today’s active lifestyles, every day athletics, and daily workouts are taking a toll on people, even in their 40s. These active patients need to get back to work and their lifestyle in short order. With the Excel program, they can recover in a

Additionally, the program greatly simplifies the healthcare billing process and provides one transparent price for the entire continuum of care. With the success of the Excel program, TCO is planning to expand the program to other TCO locations across the metro. While TCO is initiating the program with knee replacement patients, we will soon expand Excel to include all of our major procedures that would benefit by a stay in our recovery retreat. This includes shoulder, ankle, and hip surgeries. “We’ve designed Excel to provide a tremendous patient experience and high quality care,” says Simonson. “It’s where health care should go.” Owen R. O’Neill, MD, is a board-certified orthopedic surgeon and a physician in the Excel Outpatient Surgery and Recovery Program at Twin Cities Orthopedics.

Family Medicine

Join the top ranked clinic in the Twin Cities

St. Cloud/Sartell, MN We are actively recruiting exceptional full-time BE/BC Family Medicine physicians to join our primary care team at the HealthPartners Central Minnesota Clinics - Sartell. This is an out-patient clinical position. Previous electronic medical record experience is helpful, but not required. We use the Epic medical record system in all of our clinics and admitting hospitals.

A leading national consumer magazine recently recognized our clinic for providing the best care in the Twin Cities based on quality and cost. We are currently seeking new physician associates in the areas of:

Our current primary care team includes family medicine, adult medicine, OB/GYN and pediatrics. Several of our specialty services are also available onsite. Our Sartell clinic is located just one hour north of the Twin Cities and offers a dynamic lifestyle in a growing community with traditional appeal.

• Family Practice • Urgent Care We are independent physicianowned and operated primary clinic with three locations in the NW Minneapolis suburbs. Working here you will be part of an award winning team with partnership opportunities in just 2 years. We offer competitive salary and benefits. Please call to learn how you can contribute to our innovative new approaches to improving health care delivery.

private, nicely appointed suite; start therapy immediately; and recover faster.

HealthPartners Medical Group continues to receive nationally recognized clinical performance and quality awards. We offer a competitive compensation and benefit package, paid malpractice and a commitment to providing exceptional patient-centered care.

Please contact or fax CV to:

Joel Sagedahl, M.D. 5700 Bottineau Blvd., Crystal, MN 55429

Apply online at healthpartners.jobs or contact diane.m.collins@healthpartners.com. Call Diane at 952-883-5453; toll-free: 800-472-4695 x3. EOE

763-504-6600 Fax 763-504-6622

healthpartners.com

www.NWFPC.com © 2013 NAS (Media: delete copyright notice)

MN Physician 4" x 5.25" 4-color

November 2013 Minnesota Physician

37


Letters To the editor:

R

egarding the article “CSI Minnesota” by Lindsey Thomas, MD (Minnesota Physician, September 2013): I enjoyed this well-written article regarding forensic medicine. Your readers may appreciate some background on the struggle to bring forensic medicine to its current unquestioned acceptance in our community. My exposure to this interesting field was serendipitous. In 1956, I was settling comfortably into the general practice of medicine in St. Paul and Roseville. The coroner of Ramsey County, who lived in that area, stopped by one day to ask me to be a deputy coroner. In those days a body could not be moved until there was a pronouncement of death. That would be my job for my area. A short time after I started, the coroner died. A new coroner was appointed who was an attorney as well as a physician. It seemed ideal, but he soon became ill and died. The deputy investigator for the coroner’s office was a friend of my family, and called

me to ask if I might cover the office, part time, until the next election. The coroner’s office was in the Ramsey County Courthouse, and there was a morgue on Hill Street just across the street from Nina Clifford’s famous brothel. The morgue was in an old brothel of lesser fame, owned by Hattie Daniels. My first visit to the morgue was a horrible incident. A young man had taken his life and I was called to come make the pronouncement. I arrived just about the time the young man’s father had arrived. It was July, and it was hot. The morgue had a walkin cooler that could hold four bodies. There were four more wrapped in sheets placed on the floor. The young man’s body was on the marble autopsy table. Suction tubes for autopsies were hanging from a coat hanger overhead and running to an exposed toilet in a small bathroom. The father asked if I could move his son’s body to some other place for his mother to see. I was arranging this when the mother arrived. This horrible scene was embedded in my mind and I

Bach’s Brandenburg Concertos

DEC 12 Temple Israel, Minneapolis 7:00pm DEC 13 St. Philip the Deacon, Plymouth 7:00pm DEC 14 Saint Paul’s UCC, Saint Paul 7:00pm DEC 15 Trinity Lutheran Church, Stillwater 3:00pm Continuing our annual holiday tradition, the SPCO presents Bach’s most cherished set of orchestral works, the Brandenburg Concertos. These cornerstones of the Baroque literature have been praised by generations of music lovers for their profound inventiveness and dazzling instrumental virtuosity.

vowed to change the process. With the help of some friends, I formed a citizens’ committee to petition the County Commissioners to build a new facility. The St. Paul Pioneer Press was helpful in showing the public this awful place. We built a new, state-of-the-art coroner’s office and morgue facility on the Nina Clifford property. This activity kept me in the office longer than I had planned, and required that I run for election to complete the process. That was an experience. My wife was angry because I almost lost to a popular used-car salesman. At the time, you did not have to be a physician to be a coroner. I was successful in writing up a bill requiring that the coroner be a physician in Minnesota. Sen. Joe O’Neill and Sen. Nick Coleman nursed it through the legislature. We were performing about 400 autopsies a year. I used the pathologists from Ancker Hospital (now Regions Hospital) and pathology residents from Jesse Edwards’ (a famous cardiovascular pathologist)

program at Charles T. Miller Hospital and St. Luke’s Hospital (now merged to become United Hospital). I was hoping to leave the office as soon as possible. John Coe, a forensic pathologist at Hennepin County General Hospital (now Hennepin County Medical Center), had a young forensic pathologist resident who was ready to leave the program. It was a real opportunity for us to get a qualified person for the Ramsey County Coroner’s Office. I made the proposal to the county commissioners, but they did not accept it. John Coe and I formed the Minnesota Coroner and Medical Examiners Association. I was its first president, and John was the second. We held some excellent conventions and brought needed attention to this neglected office. Ramsey County and Hennepin County are now served by competent forensic pathologists, as evidenced by Lindsey Thomas, MD. Excellent article. —Thomas C. Votel, MD (retired) St. Paul, Minn.

Handel’s Messiah

DEC 20 Basilica of Saint Mary, Minneapolis 8:00pm DEC 21 Basilica of Saint Mary, Minneapolis 1:00pm Celebrate the holidays with one of classical music’s most beloved traditions as rising young British maestro Jonathan Cohen conducts Handel’s Messiah. A cherished holiday custom since its premiere in 1742, this is sure to be a wonderful musical experience for the whole family and a highlight of the Twin Cities holiday season.

order online thespco.org phone 651.291.1144 38MNPhysician_Oct.indd Minnesota 1Physician

November 2013

10/10/2013 12:31:15 PM


A landscape of opportunities

Physicians Gundersen Health System, based in LaCrosse, Wis., offers you the opportunity to practice cuttingedge medicine. But we also believe that medicine is about people and that’s why our medical outcomes are among the nation’s best (gundluth.org/ accomplishments). Currently seeking physicians for the following: • Endocrinology • Dermatology • Family Medicine • Movement Disorder Neurology • Outpatient Internal Medicine • Pulmonary Critical Care

We are a physician-led health system, where teaching and research are possible with competitive salary, benefits, CME and loan forgiveness.

Cathy Mooney (608)775-3637 cmooney@gundersenhealth.org gundersenhealth.org/MedCareers

EOE/ AA/ LEP


Relax. Discover solutions that put you at ease.

At MMIC, we believe patients get the best care when their doctors feel calm and conďŹ dent. So we put our energy into creating risk solutions designed to eliminate worry. Solutions such as medical liability insurance, physician well-being, health IT support and patient safety consulting. Itâ&#x20AC;&#x2122;s our own quiet way of revolutionizing health care. To join the Peace of Mind Movement, give us a call at 1.800.328.5532 or visit MMICgroup.com.


Minnesota Physician November 2013  

Health care infomation for Minnesota doctors Cover: One team, one bill by Owen R. O’Neil, MD Screening for risky substance use by Pam Piet...

Read more
Read more
Similar to
Popular now
Just for you